KA/EN
Register
Medicines reference
Search
Search
Active substance

Sodium chloride

Favourites

Crystalloid infusion solution. Registered in Georgia: 8 human medicines. Forms: solution.

Fluid therapy calculator →

Dose and use

Doses

We have no dose with a cited source for this substance yet.

Before use

Safety information

Known Contraindications

  • Critical
    Do not use in animals with: - Hypertonic dehydration - Hypernatraemia - Hyperchloraemia - Hyperhydration - Acidosis - Syndrome of oedema and ascites - In cases when sodium restriction is indicated.
    Sources: VMD SPC · VMD
  • Critical
    Do not use in animals with... Hyperhydration... Syndrome of oedema and ascites
    Sources: VMD SPC · VMD
  • Warning
    Use with caution in animals with cardiac or renal impairment as sodium overload may occur. The maximum infusion rate should be decreased in the presence of cardiac, renal and pulmonary disease.
    Sources: VMD SPC · VMD
  • Warning
    In cardiac disease, reduce the maximum infusion rate because of the risk of sodium overload.
    Sources: VMD SPC · VMD
  • Warning
    In renal impairment, reduce the maximum infusion rate because of the risk of sodium overload. Closely monitor electrolytes and water and acid-base balance.
    Sources: VMD SPC · VMD
  • Warning
    In pulmonary disease, reduce the maximum infusion rate. During rapid infusion, assess the animal for pulmonary oedema.
    Sources: VMD SPC · VMD
Latin name
Sodium chloride
Georgian name
ნატრიუმის ქლორიდი
Authorisation status
Authorised veterinary medicine
An authorised veterinary medicine containing this substance exists. Whether a particular use is on-label depends on the species and the indication - see each dose rule.
Registered in Georgia
8 of 9 forms
Products
Neofleks, Polifleks, Ringer lactate SEEM, Sodium Chloride-SEEM, Sodium Chloride Aculife, Sodium Chloride Braun, Sodium Chloride Dentafill Plus, Sodium Chloride Liqvor, Sodium Chloride Reka-Med
Human medicines in Georgia
Acu-NS, Ardeaelytosol natriumchlorid, Natrium Chloratum, Neofleks, Polifleks, Pro-Fleks, Serum Fizyolojik Onfarma, Sodio cloruro monico, Turkfleks
Human medicines with this substance in the Georgian register of medicines (Ministry of Health), checked on 18 Oct 2026. They are human medicines, not veterinary products; strengths and forms differ.
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026
All forms and registration9

Registration in Georgia and abroad: the register, number, validity and source are behind (i).

Neofleks 0.9%, Solution

solution for infusion, human medicine
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog Selected IV 0.9% sodium chloride for extracellular-volume replacement, chloride-responsive metabolic alkalosis, or a compatible injectable-drug diluent/flush; not default maintenance, free-water replacement or routine resuscitation fluid
6.6/10
Situational / acceptable
vetman assessment

Neofleks

0.9%, solution for infusion, human medicine
Assessed clinical scopeDog · Selected IV 0.9% sodium chloride for extracellular-volume replacement, chloride-responsive metabolic alkalosis, or a compatible injectable-drug diluent/flush; not default maintenance, free-water replacement or routine resuscitation fluid · Intravenous
Care settingVeterinary clinic or hospital after individual fluid prescription, using a pump or other volume-limiting device and repeated perfusion, body-weight, input/output, electrolyte and acid-base reassessment
vetman score 6.6/10 Situational / acceptable
Evidence confidence: Medium Georgia: Yes, human · № რ-036490, რ-036491 · Verified on 16 Oct 2026 Off-label use

A dependable clinic fluid and diluent when 154 mmol/L sodium and chloride, chloride replacement or specific compatibility is wanted. It should be prescribed like a drug, not continued by habit: balanced crystalloids are usually preferable for routine resuscitation, and volume, chloride, sodium and acid-base effects require reassessment.

Regulatory and scientific credibility5.5/10

The exact 0.9% human infusion has a sourced current Georgian registration and identifiable manufacturer, strength and IV route, while exhaustive current checks record it as not registered in EU/EEA, GB or US. Veterinary administration is off-label and no exact-product veterinary dossier was found.

Clinical efficacy6.5/10

Sodium chloride 0.9% reliably expands extracellular volume and supplies sodium and chloride, and it is useful when its composition or compatibility is specifically wanted. It is not physiologically balanced: current dog/cat guidance generally favours buffered balanced crystalloids for routine resuscitation and warns that high chloride exposure may impair acid-base and renal physiology; veterinary comparative outcome evidence remains limited.

Safety and tolerability6.5/10

Class safety is well characterised, but a public exact-product dossier was not found. Main risks are dose- and rate-related fluid overload, hypernatraemia, hyperchloraemia, acid-base disturbance, edema, contamination and line complications; renal, cardiac and oligoanuric patients, cats and small dogs require particularly tight volume control.

Clinical practicality8.5/10

A ready-to-use sterile isotonic solution fits standard IV sets, pumps and drug-dilution workflows and permits weight-based boluses or infusions. Practicality depends on selecting a bag appropriate to patient size, counting flushes and drug carriers in the total fluid prescription, maintaining asepsis, confirming additive compatibility and discarding compromised or time-expired containers.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Do not select 0.9% saline as routine ongoing fluid in existing hypernatraemia or hyperchloraemia. Measure sodium and corrected chloride, define the desired direction and rate of change, and switch or stop when the compositional target is reached.
  • Fluid overload can be life-threatening and is usually iatrogenic. Use extra caution in heart, kidney or liver disease, oliguria/anuria, pulmonary or peripheral edema, cats and small dogs; count every bolus, infusion, flush, drug carrier, enteral input and ongoing loss, and stop non-beneficial fluid.
  • At 154 mmol/L chloride, large or prolonged volumes can raise chloride and contribute to hyperchloraemic metabolic acidosis and possibly renal vasoconstriction. Recheck electrolytes, blood gas/acid-base status, creatinine, urine output and clinical perfusion; use a buffered balanced crystalloid when it better matches the patient.
  • Do not use 0.9% saline automatically as maintenance or free-water replacement. Its sodium and chloride content exceeds maintenance needs, and sodium disorders require a calculated correction plan with frequent reassessment to avoid dangerous neurologic shifts.
  • Before adding or co-infusing any medicine, confirm compatibility, final concentration, diluent, route, stability and line requirements from that medicine’s own current instructions. Inspect for haze, colour change, particles or precipitate; an isotonic carrier is not proof of chemical compatibility.
  • Prescribe a patient-specific endpoint and reassessment interval rather than a fixed universal rate. During resuscitation give measured aliquots and reassess perfusion after each; during ongoing therapy track body weight, respiratory rate/effort, edema, input/output, blood pressure and laboratory trends.
  • Use an intact, clear, particle-free container, a patient-size-appropriate bag and an accurate pump or volume-limiting device. Maintain catheter and port asepsis, follow the exact product’s post-opening limit, never pool residual fluid between patients, and discard a contaminated, damaged or expired container.
  • Pack size, container material, ports, overwrap, storage and post-opening instructions can differ among these eight exact products. The shared score does not imply interchangeability for pressure infusion, drug compounding, blood-line use or a specific delivery device; verify the exact insert before use.
Assessment sources
  1. NaCl 0.9% infusion market audit2026
  2. B. Braun NaCl 0.9% SmPC2023
  3. FDA NaCl 0.9% label2018
  4. AAHA fluid therapy guideline2024
  5. Canine crystalloid comparison2013
  6. Canine/feline hyperchloremia2025
  7. Small-animal fluid overload2021
Assessed: 22 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Cat Selected IV 0.9% sodium chloride for extracellular-volume replacement, chloride-responsive metabolic alkalosis, or a compatible injectable-drug diluent/flush; not default maintenance, free-water replacement or routine resuscitation fluid
6.6/10
Situational / acceptable
vetman assessment

Neofleks

0.9%, solution for infusion, human medicine
Assessed clinical scopeCat · Selected IV 0.9% sodium chloride for extracellular-volume replacement, chloride-responsive metabolic alkalosis, or a compatible injectable-drug diluent/flush; not default maintenance, free-water replacement or routine resuscitation fluid · Intravenous
Care settingVeterinary clinic or hospital after individual fluid prescription, using a pump or other volume-limiting device and repeated perfusion, body-weight, input/output, electrolyte and acid-base reassessment
vetman score 6.6/10 Situational / acceptable
Evidence confidence: Medium Georgia: Yes, human · № რ-036490, რ-036491 · Verified on 16 Oct 2026 Off-label use

A dependable clinic fluid and diluent when 154 mmol/L sodium and chloride, chloride replacement or specific compatibility is wanted. It should be prescribed like a drug, not continued by habit: balanced crystalloids are usually preferable for routine resuscitation, and volume, chloride, sodium and acid-base effects require reassessment.

Regulatory and scientific credibility5.5/10

The exact 0.9% human infusion has a sourced current Georgian registration and identifiable manufacturer, strength and IV route, while exhaustive current checks record it as not registered in EU/EEA, GB or US. Veterinary administration is off-label and no exact-product veterinary dossier was found.

Clinical efficacy6.5/10

Sodium chloride 0.9% reliably expands extracellular volume and supplies sodium and chloride, and it is useful when its composition or compatibility is specifically wanted. It is not physiologically balanced: current dog/cat guidance generally favours buffered balanced crystalloids for routine resuscitation and warns that high chloride exposure may impair acid-base and renal physiology; veterinary comparative outcome evidence remains limited.

Safety and tolerability6.5/10

Class safety is well characterised, but a public exact-product dossier was not found. Main risks are dose- and rate-related fluid overload, hypernatraemia, hyperchloraemia, acid-base disturbance, edema, contamination and line complications; renal, cardiac and oligoanuric patients, cats and small dogs require particularly tight volume control.

Clinical practicality8.5/10

A ready-to-use sterile isotonic solution fits standard IV sets, pumps and drug-dilution workflows and permits weight-based boluses or infusions. Practicality depends on selecting a bag appropriate to patient size, counting flushes and drug carriers in the total fluid prescription, maintaining asepsis, confirming additive compatibility and discarding compromised or time-expired containers.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Do not select 0.9% saline as routine ongoing fluid in existing hypernatraemia or hyperchloraemia. Measure sodium and corrected chloride, define the desired direction and rate of change, and switch or stop when the compositional target is reached.
  • Fluid overload can be life-threatening and is usually iatrogenic. Use extra caution in heart, kidney or liver disease, oliguria/anuria, pulmonary or peripheral edema, cats and small dogs; count every bolus, infusion, flush, drug carrier, enteral input and ongoing loss, and stop non-beneficial fluid.
  • At 154 mmol/L chloride, large or prolonged volumes can raise chloride and contribute to hyperchloraemic metabolic acidosis and possibly renal vasoconstriction. Recheck electrolytes, blood gas/acid-base status, creatinine, urine output and clinical perfusion; use a buffered balanced crystalloid when it better matches the patient.
  • Do not use 0.9% saline automatically as maintenance or free-water replacement. Its sodium and chloride content exceeds maintenance needs, and sodium disorders require a calculated correction plan with frequent reassessment to avoid dangerous neurologic shifts.
  • Before adding or co-infusing any medicine, confirm compatibility, final concentration, diluent, route, stability and line requirements from that medicine’s own current instructions. Inspect for haze, colour change, particles or precipitate; an isotonic carrier is not proof of chemical compatibility.
  • Prescribe a patient-specific endpoint and reassessment interval rather than a fixed universal rate. During resuscitation give measured aliquots and reassess perfusion after each; during ongoing therapy track body weight, respiratory rate/effort, edema, input/output, blood pressure and laboratory trends.
  • Use an intact, clear, particle-free container, a patient-size-appropriate bag and an accurate pump or volume-limiting device. Maintain catheter and port asepsis, follow the exact product’s post-opening limit, never pool residual fluid between patients, and discard a contaminated, damaged or expired container.
  • Pack size, container material, ports, overwrap, storage and post-opening instructions can differ among these eight exact products. The shared score does not imply interchangeability for pressure infusion, drug compounding, blood-line use or a specific delivery device; verify the exact insert before use.
Assessment sources
  1. NaCl 0.9% infusion market audit2026
  2. B. Braun NaCl 0.9% SmPC2023
  3. FDA NaCl 0.9% label2018
  4. AAHA fluid therapy guideline2024
  5. Canine crystalloid comparison2013
  6. Canine/feline hyperchloremia2025
  7. Small-animal fluid overload2021
Assessed: 22 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Sodium chloride9 mg/ml
Formulation Type
Solution
Administration route
Intravenous
Manufacturer
Turktipsan · Türkiye
Registration
Georgia Yes, human
In force until 26 Sep 2027
Human (Ministry of Health, RAMA)
In the register: ნეოფლექსი 0.9%, საინფუზიო ხსნარი
№ რ-036490, რ-036491
Verified on: 16 Oct 2026
 EU No
Verified on: 16 Oct 2026
 UK No
Verified on: 16 Oct 2026
 US No
Verified on: 16 Oct 2026
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026

Polifleks 0.9%, Solution

solution for infusion, human medicine
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog Selected IV 0.9% sodium chloride for extracellular-volume replacement, chloride-responsive metabolic alkalosis, or a compatible injectable-drug diluent/flush; not default maintenance, free-water replacement or routine resuscitation fluid
6.6/10
Situational / acceptable
vetman assessment

Polifleks

0.9%, solution for infusion, human medicine
Assessed clinical scopeDog · Selected IV 0.9% sodium chloride for extracellular-volume replacement, chloride-responsive metabolic alkalosis, or a compatible injectable-drug diluent/flush; not default maintenance, free-water replacement or routine resuscitation fluid · Intravenous
Care settingVeterinary clinic or hospital after individual fluid prescription, using a pump or other volume-limiting device and repeated perfusion, body-weight, input/output, electrolyte and acid-base reassessment
vetman score 6.6/10 Situational / acceptable
Evidence confidence: Medium Georgia: Yes, human · № რ-046137, რ-046138, რ-046139 · Verified on 16 Oct 2026 Off-label use

A dependable clinic fluid and diluent when 154 mmol/L sodium and chloride, chloride replacement or specific compatibility is wanted. It should be prescribed like a drug, not continued by habit: balanced crystalloids are usually preferable for routine resuscitation, and volume, chloride, sodium and acid-base effects require reassessment.

Regulatory and scientific credibility5.5/10

The exact 0.9% human infusion has a sourced current Georgian registration and identifiable manufacturer, strength and IV route, while exhaustive current checks record it as not registered in EU/EEA, GB or US. Veterinary administration is off-label and no exact-product veterinary dossier was found.

Clinical efficacy6.5/10

Sodium chloride 0.9% reliably expands extracellular volume and supplies sodium and chloride, and it is useful when its composition or compatibility is specifically wanted. It is not physiologically balanced: current dog/cat guidance generally favours buffered balanced crystalloids for routine resuscitation and warns that high chloride exposure may impair acid-base and renal physiology; veterinary comparative outcome evidence remains limited.

Safety and tolerability6.5/10

Class safety is well characterised, but a public exact-product dossier was not found. Main risks are dose- and rate-related fluid overload, hypernatraemia, hyperchloraemia, acid-base disturbance, edema, contamination and line complications; renal, cardiac and oligoanuric patients, cats and small dogs require particularly tight volume control.

Clinical practicality8.5/10

A ready-to-use sterile isotonic solution fits standard IV sets, pumps and drug-dilution workflows and permits weight-based boluses or infusions. Practicality depends on selecting a bag appropriate to patient size, counting flushes and drug carriers in the total fluid prescription, maintaining asepsis, confirming additive compatibility and discarding compromised or time-expired containers.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Do not select 0.9% saline as routine ongoing fluid in existing hypernatraemia or hyperchloraemia. Measure sodium and corrected chloride, define the desired direction and rate of change, and switch or stop when the compositional target is reached.
  • Fluid overload can be life-threatening and is usually iatrogenic. Use extra caution in heart, kidney or liver disease, oliguria/anuria, pulmonary or peripheral edema, cats and small dogs; count every bolus, infusion, flush, drug carrier, enteral input and ongoing loss, and stop non-beneficial fluid.
  • At 154 mmol/L chloride, large or prolonged volumes can raise chloride and contribute to hyperchloraemic metabolic acidosis and possibly renal vasoconstriction. Recheck electrolytes, blood gas/acid-base status, creatinine, urine output and clinical perfusion; use a buffered balanced crystalloid when it better matches the patient.
  • Do not use 0.9% saline automatically as maintenance or free-water replacement. Its sodium and chloride content exceeds maintenance needs, and sodium disorders require a calculated correction plan with frequent reassessment to avoid dangerous neurologic shifts.
  • Before adding or co-infusing any medicine, confirm compatibility, final concentration, diluent, route, stability and line requirements from that medicine’s own current instructions. Inspect for haze, colour change, particles or precipitate; an isotonic carrier is not proof of chemical compatibility.
  • Prescribe a patient-specific endpoint and reassessment interval rather than a fixed universal rate. During resuscitation give measured aliquots and reassess perfusion after each; during ongoing therapy track body weight, respiratory rate/effort, edema, input/output, blood pressure and laboratory trends.
  • Use an intact, clear, particle-free container, a patient-size-appropriate bag and an accurate pump or volume-limiting device. Maintain catheter and port asepsis, follow the exact product’s post-opening limit, never pool residual fluid between patients, and discard a contaminated, damaged or expired container.
  • Pack size, container material, ports, overwrap, storage and post-opening instructions can differ among these eight exact products. The shared score does not imply interchangeability for pressure infusion, drug compounding, blood-line use or a specific delivery device; verify the exact insert before use.
Assessment sources
  1. NaCl 0.9% infusion market audit2026
  2. B. Braun NaCl 0.9% SmPC2023
  3. FDA NaCl 0.9% label2018
  4. AAHA fluid therapy guideline2024
  5. Canine crystalloid comparison2013
  6. Canine/feline hyperchloremia2025
  7. Small-animal fluid overload2021
Assessed: 22 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Cat Selected IV 0.9% sodium chloride for extracellular-volume replacement, chloride-responsive metabolic alkalosis, or a compatible injectable-drug diluent/flush; not default maintenance, free-water replacement or routine resuscitation fluid
6.6/10
Situational / acceptable
vetman assessment

Polifleks

0.9%, solution for infusion, human medicine
Assessed clinical scopeCat · Selected IV 0.9% sodium chloride for extracellular-volume replacement, chloride-responsive metabolic alkalosis, or a compatible injectable-drug diluent/flush; not default maintenance, free-water replacement or routine resuscitation fluid · Intravenous
Care settingVeterinary clinic or hospital after individual fluid prescription, using a pump or other volume-limiting device and repeated perfusion, body-weight, input/output, electrolyte and acid-base reassessment
vetman score 6.6/10 Situational / acceptable
Evidence confidence: Medium Georgia: Yes, human · № რ-046137, რ-046138, რ-046139 · Verified on 16 Oct 2026 Off-label use

A dependable clinic fluid and diluent when 154 mmol/L sodium and chloride, chloride replacement or specific compatibility is wanted. It should be prescribed like a drug, not continued by habit: balanced crystalloids are usually preferable for routine resuscitation, and volume, chloride, sodium and acid-base effects require reassessment.

Regulatory and scientific credibility5.5/10

The exact 0.9% human infusion has a sourced current Georgian registration and identifiable manufacturer, strength and IV route, while exhaustive current checks record it as not registered in EU/EEA, GB or US. Veterinary administration is off-label and no exact-product veterinary dossier was found.

Clinical efficacy6.5/10

Sodium chloride 0.9% reliably expands extracellular volume and supplies sodium and chloride, and it is useful when its composition or compatibility is specifically wanted. It is not physiologically balanced: current dog/cat guidance generally favours buffered balanced crystalloids for routine resuscitation and warns that high chloride exposure may impair acid-base and renal physiology; veterinary comparative outcome evidence remains limited.

Safety and tolerability6.5/10

Class safety is well characterised, but a public exact-product dossier was not found. Main risks are dose- and rate-related fluid overload, hypernatraemia, hyperchloraemia, acid-base disturbance, edema, contamination and line complications; renal, cardiac and oligoanuric patients, cats and small dogs require particularly tight volume control.

Clinical practicality8.5/10

A ready-to-use sterile isotonic solution fits standard IV sets, pumps and drug-dilution workflows and permits weight-based boluses or infusions. Practicality depends on selecting a bag appropriate to patient size, counting flushes and drug carriers in the total fluid prescription, maintaining asepsis, confirming additive compatibility and discarding compromised or time-expired containers.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Do not select 0.9% saline as routine ongoing fluid in existing hypernatraemia or hyperchloraemia. Measure sodium and corrected chloride, define the desired direction and rate of change, and switch or stop when the compositional target is reached.
  • Fluid overload can be life-threatening and is usually iatrogenic. Use extra caution in heart, kidney or liver disease, oliguria/anuria, pulmonary or peripheral edema, cats and small dogs; count every bolus, infusion, flush, drug carrier, enteral input and ongoing loss, and stop non-beneficial fluid.
  • At 154 mmol/L chloride, large or prolonged volumes can raise chloride and contribute to hyperchloraemic metabolic acidosis and possibly renal vasoconstriction. Recheck electrolytes, blood gas/acid-base status, creatinine, urine output and clinical perfusion; use a buffered balanced crystalloid when it better matches the patient.
  • Do not use 0.9% saline automatically as maintenance or free-water replacement. Its sodium and chloride content exceeds maintenance needs, and sodium disorders require a calculated correction plan with frequent reassessment to avoid dangerous neurologic shifts.
  • Before adding or co-infusing any medicine, confirm compatibility, final concentration, diluent, route, stability and line requirements from that medicine’s own current instructions. Inspect for haze, colour change, particles or precipitate; an isotonic carrier is not proof of chemical compatibility.
  • Prescribe a patient-specific endpoint and reassessment interval rather than a fixed universal rate. During resuscitation give measured aliquots and reassess perfusion after each; during ongoing therapy track body weight, respiratory rate/effort, edema, input/output, blood pressure and laboratory trends.
  • Use an intact, clear, particle-free container, a patient-size-appropriate bag and an accurate pump or volume-limiting device. Maintain catheter and port asepsis, follow the exact product’s post-opening limit, never pool residual fluid between patients, and discard a contaminated, damaged or expired container.
  • Pack size, container material, ports, overwrap, storage and post-opening instructions can differ among these eight exact products. The shared score does not imply interchangeability for pressure infusion, drug compounding, blood-line use or a specific delivery device; verify the exact insert before use.
Assessment sources
  1. NaCl 0.9% infusion market audit2026
  2. B. Braun NaCl 0.9% SmPC2023
  3. FDA NaCl 0.9% label2018
  4. AAHA fluid therapy guideline2024
  5. Canine crystalloid comparison2013
  6. Canine/feline hyperchloremia2025
  7. Small-animal fluid overload2021
Assessed: 22 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Sodium chloride9 mg/ml
Formulation Type
Solution
Administration route
Intravenous
Manufacturer
Polifarma Ilac · Türkiye
Registration
Georgia Yes, human
In force until 11 Aug 2031
Human (Ministry of Health, RAMA)
In the register: პოლიფლექსი 0.9%, საინფუზიო ხსნარი
№ რ-046137, რ-046138, რ-046139
Verified on: 16 Oct 2026
 EU No
Verified on: 16 Oct 2026
 UK No
Verified on: 16 Oct 2026
 US No
Verified on: 16 Oct 2026
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026

Ringer lactate SEEM, Solution

solution for infusion, human medicine
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog IV buffered-isotonic crystalloid resuscitation of confirmed hypovolaemia
6.6/10
Situational / acceptable
vetman assessment

Ringer lactate SEEM

solution for infusion, human medicine
Assessed clinical scopeDog · IV buffered-isotonic crystalloid resuscitation of confirmed hypovolaemia · Intravenous
Care settingEmergency/critical-care IV bolus with perfusion reassessment after every 15–20 mL/kg over 15–30 min; not routine fluid loading of a euvolaemic patient.
vetman score 6.6/10 Situational / acceptable
Evidence confidence: Medium Georgia: No longer listed · № რ-032747, რ-032746 · Verified on 22 Oct 2026 Off-label use

A standard class-level resuscitation fluid with a credible dog regimen, but this exact human presentation has expired Georgian authorisation and no recognised veterinary dossier. Use only for true hypovolaemia, in small reassessed boluses—not a fixed shock-volume target.

Regulatory and scientific credibility4.5/10

Exact composition and manufacturer instruction are verifiable and a 2022 Uzbek state register corroborates identity and historical legal-market status, but the Georgian certificates expired. The reviewed EU/GB/US searches did not establish current exact-product status and lack the documented same-endpoint positive controls required to prove non-authorisation; veterinary use is off-label and no recognised-regulator veterinary dossier for this presentation was verified.

Clinical efficacy8.0/10

Buffered isotonic crystalloids are a guideline-standard replacement option for the assessed role; benefit is well established at class level, while exact-product veterinary outcome trials are absent and response depends on diagnosis, volume and reassessment.

Safety and tolerability6.5/10

Predictable class risks are manageable with selection and monitoring, but overload, pulmonary oedema, electrolyte/acid-base shifts and calcium-containing admixture incompatibilities can be serious; exact-product veterinary pharmacovigilance is limited.

Clinical practicality8.0/10

A ready-to-infuse 250/500 mL solution is workable in emergency care with IV access and a pump or calibrated set; benefit depends on rapid reassessment, cumulative-volume tracking, asepsis and an alternative line for incompatible infusions.

Full-course cost-effectiveness-

A current Georgian exact-pack price and patient-specific treatment cost were not verified; price is excluded from the denominator.

Important safety and use flags

  • Stop the infusion and urgently reassess restlessness, tachypnoea/increased effort, moist lung sounds, cough, nasal discharge, oedema, rapid weight gain or other suspected fluid overload/pulmonary oedema.
  • Do not use as routine volume loading in a euvolaemic patient or with existing overhydration/pulmonary oedema. Exact SEEM also lists alkalosis, severe hepatic dysfunction, acute renal failure, lactic acidosis and hypertonic dehydration as contraindications.
  • Individualise fluid type, bolus/rate and cumulative volume from perfusion, weight, urine output, blood pressure, respiratory/lung findings, electrolytes, acid-base state, concurrent enteral/drug fluids and ongoing losses; risk is higher in cats and cardiac/renal patients.
  • Do not mix with phosphate- or carbonate-containing solutions or use as a routine drug diluent/carrier. Verify exact admixture and Y-site compatibility before adding or co-infusing any medicine; use a separate line when compatibility is unknown.
  • Because the solution contains calcium, do not co-infuse blood through the same set unless an exact institutional compatibility protocol explicitly permits it; do not add calcium-chelating or otherwise incompatible medicines.
  • Review potassium supplements, potassium-sparing diuretics and ACE inhibitors for hyperkalaemia risk. Calcium may increase cardiac-glycoside toxicity; use only with deliberate monitoring and verified compatibility.
  • This is a human SEEM presentation used off-label in dogs and cats. Exact-product veterinary sterility/quality dossier, outcome trials and recognised-regulator pharmacovigilance were not located; class evidence and a composition-near authorised veterinary comparator support clinical transfer, not exact-product equivalence.
  • Lactated Ringer's is a replacement crystalloid, not automatically the right long-term maintenance fluid. Prolonged isotonic use may cause sodium derangement and hypokalaemia; reassess fluid composition when the patient is euvolaemic.
  • Use aseptic IV technique and calibrated delivery; inspect container integrity and solution clarity, never use a leaking/cloudy/particulate container, dedicate opened product to one patient and discard unused contents according to the exact pack instruction.
Assessment sources
  1. SEEM exact instruction2026
  2. UZ exact register2022
  3. GE SEEM audit2026
  4. SEEM EU-GB-US checks2026
  5. AAHA fluid guideline2024
  6. AAHA fluid controversies2024
  7. Veterinary Hartmann comparator2026
Assessed: 23 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Dog IV replacement of calculated extracellular dehydration deficit and ongoing losses
6.8/10
Situational / acceptable
vetman assessment

Ringer lactate SEEM

solution for infusion, human medicine
Assessed clinical scopeDog · IV replacement of calculated extracellular dehydration deficit and ongoing losses · Intravenous
Care settingHospital IV rehydration: calculate deficit and replace over 12–24 h, add measured ongoing losses and oral/enteral/medication fluids, and reassess weight, hydration, urine output and chemistry.
vetman score 6.8/10 Situational / acceptable
Evidence confidence: Medium Georgia: No longer listed · № რ-032747, რ-032746 · Verified on 22 Oct 2026 Off-label use

A useful buffered replacement fluid for calculated canine dehydration when composition matches the patient. It should not become an unmonitored long-term maintenance default, and exact SEEM quality/regulatory support remains weaker than recognised veterinary alternatives.

Regulatory and scientific credibility4.5/10

Exact composition and manufacturer instruction are verifiable and a 2022 Uzbek state register corroborates identity and historical legal-market status, but the Georgian certificates expired. The reviewed EU/GB/US searches did not establish current exact-product status and lack the documented same-endpoint positive controls required to prove non-authorisation; veterinary use is off-label and no recognised-regulator veterinary dossier for this presentation was verified.

Clinical efficacy8.0/10

Buffered isotonic crystalloids are a guideline-standard replacement option for the assessed role; benefit is well established at class level, while exact-product veterinary outcome trials are absent and response depends on diagnosis, volume and reassessment.

Safety and tolerability7.0/10

Slower deficit replacement is generally controllable with serial assessment, but overload and electrolyte/acid-base shifts remain possible, especially with renal/cardiac/hepatic disease or prolonged use as maintenance; exact-product veterinary surveillance is limited.

Clinical practicality8.0/10

Ready-to-infuse packs fit hospital rehydration, but correct use requires deficit and ongoing-loss calculations, infusion control, intake/output accounting, repeat examination and chemistry-guided adjustment rather than a default hourly rate.

Full-course cost-effectiveness-

A current Georgian exact-pack price and patient-specific treatment cost were not verified; price is excluded from the denominator.

Important safety and use flags

  • Stop the infusion and urgently reassess restlessness, tachypnoea/increased effort, moist lung sounds, cough, nasal discharge, oedema, rapid weight gain or other suspected fluid overload/pulmonary oedema.
  • Do not use as routine volume loading in a euvolaemic patient or with existing overhydration/pulmonary oedema. Exact SEEM also lists alkalosis, severe hepatic dysfunction, acute renal failure, lactic acidosis and hypertonic dehydration as contraindications.
  • Individualise fluid type, bolus/rate and cumulative volume from perfusion, weight, urine output, blood pressure, respiratory/lung findings, electrolytes, acid-base state, concurrent enteral/drug fluids and ongoing losses; risk is higher in cats and cardiac/renal patients.
  • Do not mix with phosphate- or carbonate-containing solutions or use as a routine drug diluent/carrier. Verify exact admixture and Y-site compatibility before adding or co-infusing any medicine; use a separate line when compatibility is unknown.
  • Because the solution contains calcium, do not co-infuse blood through the same set unless an exact institutional compatibility protocol explicitly permits it; do not add calcium-chelating or otherwise incompatible medicines.
  • Review potassium supplements, potassium-sparing diuretics and ACE inhibitors for hyperkalaemia risk. Calcium may increase cardiac-glycoside toxicity; use only with deliberate monitoring and verified compatibility.
  • This is a human SEEM presentation used off-label in dogs and cats. Exact-product veterinary sterility/quality dossier, outcome trials and recognised-regulator pharmacovigilance were not located; class evidence and a composition-near authorised veterinary comparator support clinical transfer, not exact-product equivalence.
  • Lactated Ringer's is a replacement crystalloid, not automatically the right long-term maintenance fluid. Prolonged isotonic use may cause sodium derangement and hypokalaemia; reassess fluid composition when the patient is euvolaemic.
  • Use aseptic IV technique and calibrated delivery; inspect container integrity and solution clarity, never use a leaking/cloudy/particulate container, dedicate opened product to one patient and discard unused contents according to the exact pack instruction.
Assessment sources
  1. SEEM exact instruction2026
  2. UZ exact register2022
  3. GE SEEM audit2026
  4. SEEM EU-GB-US checks2026
  5. AAHA fluid guideline2024
  6. AAHA fluid controversies2024
  7. Veterinary Hartmann comparator2026
Assessed: 23 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Cat IV buffered-isotonic crystalloid resuscitation of confirmed hypovolaemia
6.2/10
Situational / acceptable
vetman assessment

Ringer lactate SEEM

solution for infusion, human medicine
Assessed clinical scopeCat · IV buffered-isotonic crystalloid resuscitation of confirmed hypovolaemia · Intravenous
Care settingEmergency/critical-care IV bolus with perfusion reassessment after every 5–10 mL/kg over 15–30 min and particularly strict cumulative-volume surveillance.
vetman score 6.2/10 Situational / acceptable
Evidence confidence: Medium Georgia: No longer listed · № რ-032747, რ-032746 · Verified on 22 Oct 2026 Off-label use

A clinically useful class-level option for feline hypovolaemia, but the exact product has regulatory/evidence limitations and cats require conservative 5–10 mL/kg reassessed boluses with vigilant overload monitoring.

Regulatory and scientific credibility4.5/10

Exact composition and manufacturer instruction are verifiable and a 2022 Uzbek state register corroborates identity and historical legal-market status, but the Georgian certificates expired. The reviewed EU/GB/US searches did not establish current exact-product status and lack the documented same-endpoint positive controls required to prove non-authorisation; veterinary use is off-label and no recognised-regulator veterinary dossier for this presentation was verified.

Clinical efficacy8.0/10

Buffered isotonic crystalloids are a guideline-standard replacement option for the assessed role; benefit is well established at class level, while exact-product veterinary outcome trials are absent and response depends on diagnosis, volume and reassessment.

Safety and tolerability6.0/10

Cats have a narrower practical margin for fluid intolerance and occult cardiac disease; overload/pulmonary oedema may develop quickly, while electrolyte/acid-base shifts and calcium-containing admixture incompatibilities remain and exact-product veterinary safety data are absent.

Clinical practicality6.5/10

The 250 mL presentation and small-bolus guidance are usable in hospital, but feline dosing needs precise low-volume delivery, frequent reassessment and meticulous cumulative accounting; larger packs may create waste or dosing risk.

Full-course cost-effectiveness-

A current Georgian exact-pack price and patient-specific treatment cost were not verified; price is excluded from the denominator.

Important safety and use flags

  • Stop the infusion and urgently reassess restlessness, tachypnoea/increased effort, moist lung sounds, cough, nasal discharge, oedema, rapid weight gain or other suspected fluid overload/pulmonary oedema.
  • Do not use as routine volume loading in a euvolaemic patient or with existing overhydration/pulmonary oedema. Exact SEEM also lists alkalosis, severe hepatic dysfunction, acute renal failure, lactic acidosis and hypertonic dehydration as contraindications.
  • Individualise fluid type, bolus/rate and cumulative volume from perfusion, weight, urine output, blood pressure, respiratory/lung findings, electrolytes, acid-base state, concurrent enteral/drug fluids and ongoing losses; risk is higher in cats and cardiac/renal patients.
  • Do not mix with phosphate- or carbonate-containing solutions or use as a routine drug diluent/carrier. Verify exact admixture and Y-site compatibility before adding or co-infusing any medicine; use a separate line when compatibility is unknown.
  • Because the solution contains calcium, do not co-infuse blood through the same set unless an exact institutional compatibility protocol explicitly permits it; do not add calcium-chelating or otherwise incompatible medicines.
  • Review potassium supplements, potassium-sparing diuretics and ACE inhibitors for hyperkalaemia risk. Calcium may increase cardiac-glycoside toxicity; use only with deliberate monitoring and verified compatibility.
  • This is a human SEEM presentation used off-label in dogs and cats. Exact-product veterinary sterility/quality dossier, outcome trials and recognised-regulator pharmacovigilance were not located; class evidence and a composition-near authorised veterinary comparator support clinical transfer, not exact-product equivalence.
  • Lactated Ringer's is a replacement crystalloid, not automatically the right long-term maintenance fluid. Prolonged isotonic use may cause sodium derangement and hypokalaemia; reassess fluid composition when the patient is euvolaemic.
  • Use aseptic IV technique and calibrated delivery; inspect container integrity and solution clarity, never use a leaking/cloudy/particulate container, dedicate opened product to one patient and discard unused contents according to the exact pack instruction.
Assessment sources
  1. SEEM exact instruction2026
  2. UZ exact register2022
  3. GE SEEM audit2026
  4. SEEM EU-GB-US checks2026
  5. AAHA fluid guideline2024
  6. AAHA fluid controversies2024
  7. Veterinary Hartmann comparator2026
Assessed: 23 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Cat IV replacement of calculated extracellular dehydration deficit and ongoing losses
6.4/10
Situational / acceptable
vetman assessment

Ringer lactate SEEM

solution for infusion, human medicine
Assessed clinical scopeCat · IV replacement of calculated extracellular dehydration deficit and ongoing losses · Intravenous
Care settingHospital IV rehydration: replace the calculated deficit over 12–24 h with strict cumulative-fluid, weight, respiratory, urine-output and chemistry monitoring.
vetman score 6.4/10 Situational / acceptable
Evidence confidence: Medium Georgia: No longer listed · № რ-032747, რ-032746 · Verified on 22 Oct 2026 Off-label use

Useful for calculated feline extracellular dehydration under close monitoring, but the narrower feline volume margin and exact-product regulatory/evidence limitations keep it situational rather than a preferred default.

Regulatory and scientific credibility4.5/10

Exact composition and manufacturer instruction are verifiable and a 2022 Uzbek state register corroborates identity and historical legal-market status, but the Georgian certificates expired. The reviewed EU/GB/US searches did not establish current exact-product status and lack the documented same-endpoint positive controls required to prove non-authorisation; veterinary use is off-label and no recognised-regulator veterinary dossier for this presentation was verified.

Clinical efficacy8.0/10

Buffered isotonic crystalloids are a guideline-standard replacement option for the assessed role; benefit is well established at class level, while exact-product veterinary outcome trials are absent and response depends on diagnosis, volume and reassessment.

Safety and tolerability6.0/10

Controlled replacement is effective, but cats are prone to occult cardiac disease and fluid intolerance; overload, pulmonary oedema and electrolyte shifts require closer surveillance, and exact-product feline safety/pharmacovigilance data are absent.

Clinical practicality7.5/10

The 250 mL pack can support precise hospital rehydration, but cats need low-volume calibrated delivery, full accounting of enteral/drug fluids and frequent reassessment; this isotonic fluid is not automatically suitable for prolonged maintenance.

Full-course cost-effectiveness-

A current Georgian exact-pack price and patient-specific treatment cost were not verified; price is excluded from the denominator.

Important safety and use flags

  • Stop the infusion and urgently reassess restlessness, tachypnoea/increased effort, moist lung sounds, cough, nasal discharge, oedema, rapid weight gain or other suspected fluid overload/pulmonary oedema.
  • Do not use as routine volume loading in a euvolaemic patient or with existing overhydration/pulmonary oedema. Exact SEEM also lists alkalosis, severe hepatic dysfunction, acute renal failure, lactic acidosis and hypertonic dehydration as contraindications.
  • Individualise fluid type, bolus/rate and cumulative volume from perfusion, weight, urine output, blood pressure, respiratory/lung findings, electrolytes, acid-base state, concurrent enteral/drug fluids and ongoing losses; risk is higher in cats and cardiac/renal patients.
  • Do not mix with phosphate- or carbonate-containing solutions or use as a routine drug diluent/carrier. Verify exact admixture and Y-site compatibility before adding or co-infusing any medicine; use a separate line when compatibility is unknown.
  • Because the solution contains calcium, do not co-infuse blood through the same set unless an exact institutional compatibility protocol explicitly permits it; do not add calcium-chelating or otherwise incompatible medicines.
  • Review potassium supplements, potassium-sparing diuretics and ACE inhibitors for hyperkalaemia risk. Calcium may increase cardiac-glycoside toxicity; use only with deliberate monitoring and verified compatibility.
  • This is a human SEEM presentation used off-label in dogs and cats. Exact-product veterinary sterility/quality dossier, outcome trials and recognised-regulator pharmacovigilance were not located; class evidence and a composition-near authorised veterinary comparator support clinical transfer, not exact-product equivalence.
  • Lactated Ringer's is a replacement crystalloid, not automatically the right long-term maintenance fluid. Prolonged isotonic use may cause sodium derangement and hypokalaemia; reassess fluid composition when the patient is euvolaemic.
  • Use aseptic IV technique and calibrated delivery; inspect container integrity and solution clarity, never use a leaking/cloudy/particulate container, dedicate opened product to one patient and discard unused contents according to the exact pack instruction.
Assessment sources
  1. SEEM exact instruction2026
  2. UZ exact register2022
  3. GE SEEM audit2026
  4. SEEM EU-GB-US checks2026
  5. AAHA fluid guideline2024
  6. AAHA fluid controversies2024
  7. Veterinary Hartmann comparator2026
Assessed: 23 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Sodium chloride6 mg/ml Potassium chloride0.4 mg/ml Calcium chloride0.27 mg/ml Sodium lactate3.2 mg/ml
Formulation Type
Solution
Administration route
Intravenous
Manufacturer
Samarkand England Eco-Medical · Uzbekistan
Registration
Georgia No longer listed
Was registered; not in the current register
Human (Ministry of Health, RAMA)
In the register: რინგერი ლაქტატით
№ რ-032747, რ-032746
Verified on: 22 Oct 2026
 EU Not confirmed
Verified on: 16 Oct 2026
 UK Not confirmed
Verified on: 16 Oct 2026
 US Not confirmed
Verified on: 16 Oct 2026
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026
Information not fully verified Veterinary use is off-label. Hypovolaemia: dog 15–20 mL/kg IV over 15–30 min; cat 5–10 mL/kg IV over 15–30 min, reassessing perfusion after each bolus. Dehydration: calculate deficit as body weight × dehydration fraction and replace over 12–24 h, adding ongoing losses. Do not transfer the human 2500 mL/day or drop-rate instruction to animals. This isotonic replacement fluid is not automatically an appropriate long-term maintenance fluid.

Sodium Chloride-SEEM 0.9%, Solution

solution for infusion, human medicine
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog Selected IV 0.9% sodium chloride for extracellular-volume replacement, chloride-responsive metabolic alkalosis, or a compatible injectable-drug diluent/flush; not default maintenance, free-water replacement or routine resuscitation fluid
6.6/10
Situational / acceptable
vetman assessment

Sodium Chloride-SEEM

0.9%, solution for infusion, human medicine
Assessed clinical scopeDog · Selected IV 0.9% sodium chloride for extracellular-volume replacement, chloride-responsive metabolic alkalosis, or a compatible injectable-drug diluent/flush; not default maintenance, free-water replacement or routine resuscitation fluid · Intravenous
Care settingVeterinary clinic or hospital after individual fluid prescription, using a pump or other volume-limiting device and repeated perfusion, body-weight, input/output, electrolyte and acid-base reassessment
vetman score 6.6/10 Situational / acceptable
Evidence confidence: Medium Georgia: Yes, human · № რ-035499, რ-035500, რ-035501 · Verified on 16 Oct 2026 Off-label use

A dependable clinic fluid and diluent when 154 mmol/L sodium and chloride, chloride replacement or specific compatibility is wanted. It should be prescribed like a drug, not continued by habit: balanced crystalloids are usually preferable for routine resuscitation, and volume, chloride, sodium and acid-base effects require reassessment.

Regulatory and scientific credibility5.5/10

The exact 0.9% human infusion has a sourced current Georgian registration and identifiable manufacturer, strength and IV route, while exhaustive current checks record it as not registered in EU/EEA, GB or US. Veterinary administration is off-label and no exact-product veterinary dossier was found.

Clinical efficacy6.5/10

Sodium chloride 0.9% reliably expands extracellular volume and supplies sodium and chloride, and it is useful when its composition or compatibility is specifically wanted. It is not physiologically balanced: current dog/cat guidance generally favours buffered balanced crystalloids for routine resuscitation and warns that high chloride exposure may impair acid-base and renal physiology; veterinary comparative outcome evidence remains limited.

Safety and tolerability6.5/10

Class safety is well characterised, but a public exact-product dossier was not found. Main risks are dose- and rate-related fluid overload, hypernatraemia, hyperchloraemia, acid-base disturbance, edema, contamination and line complications; renal, cardiac and oligoanuric patients, cats and small dogs require particularly tight volume control.

Clinical practicality8.5/10

A ready-to-use sterile isotonic solution fits standard IV sets, pumps and drug-dilution workflows and permits weight-based boluses or infusions. Practicality depends on selecting a bag appropriate to patient size, counting flushes and drug carriers in the total fluid prescription, maintaining asepsis, confirming additive compatibility and discarding compromised or time-expired containers.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Do not select 0.9% saline as routine ongoing fluid in existing hypernatraemia or hyperchloraemia. Measure sodium and corrected chloride, define the desired direction and rate of change, and switch or stop when the compositional target is reached.
  • Fluid overload can be life-threatening and is usually iatrogenic. Use extra caution in heart, kidney or liver disease, oliguria/anuria, pulmonary or peripheral edema, cats and small dogs; count every bolus, infusion, flush, drug carrier, enteral input and ongoing loss, and stop non-beneficial fluid.
  • At 154 mmol/L chloride, large or prolonged volumes can raise chloride and contribute to hyperchloraemic metabolic acidosis and possibly renal vasoconstriction. Recheck electrolytes, blood gas/acid-base status, creatinine, urine output and clinical perfusion; use a buffered balanced crystalloid when it better matches the patient.
  • Do not use 0.9% saline automatically as maintenance or free-water replacement. Its sodium and chloride content exceeds maintenance needs, and sodium disorders require a calculated correction plan with frequent reassessment to avoid dangerous neurologic shifts.
  • Before adding or co-infusing any medicine, confirm compatibility, final concentration, diluent, route, stability and line requirements from that medicine’s own current instructions. Inspect for haze, colour change, particles or precipitate; an isotonic carrier is not proof of chemical compatibility.
  • Prescribe a patient-specific endpoint and reassessment interval rather than a fixed universal rate. During resuscitation give measured aliquots and reassess perfusion after each; during ongoing therapy track body weight, respiratory rate/effort, edema, input/output, blood pressure and laboratory trends.
  • Use an intact, clear, particle-free container, a patient-size-appropriate bag and an accurate pump or volume-limiting device. Maintain catheter and port asepsis, follow the exact product’s post-opening limit, never pool residual fluid between patients, and discard a contaminated, damaged or expired container.
  • Pack size, container material, ports, overwrap, storage and post-opening instructions can differ among these eight exact products. The shared score does not imply interchangeability for pressure infusion, drug compounding, blood-line use or a specific delivery device; verify the exact insert before use.
Assessment sources
  1. NaCl 0.9% infusion market audit2026
  2. B. Braun NaCl 0.9% SmPC2023
  3. FDA NaCl 0.9% label2018
  4. AAHA fluid therapy guideline2024
  5. Canine crystalloid comparison2013
  6. Canine/feline hyperchloremia2025
  7. Small-animal fluid overload2021
Assessed: 22 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Cat Selected IV 0.9% sodium chloride for extracellular-volume replacement, chloride-responsive metabolic alkalosis, or a compatible injectable-drug diluent/flush; not default maintenance, free-water replacement or routine resuscitation fluid
6.6/10
Situational / acceptable
vetman assessment

Sodium Chloride-SEEM

0.9%, solution for infusion, human medicine
Assessed clinical scopeCat · Selected IV 0.9% sodium chloride for extracellular-volume replacement, chloride-responsive metabolic alkalosis, or a compatible injectable-drug diluent/flush; not default maintenance, free-water replacement or routine resuscitation fluid · Intravenous
Care settingVeterinary clinic or hospital after individual fluid prescription, using a pump or other volume-limiting device and repeated perfusion, body-weight, input/output, electrolyte and acid-base reassessment
vetman score 6.6/10 Situational / acceptable
Evidence confidence: Medium Georgia: Yes, human · № რ-035499, რ-035500, რ-035501 · Verified on 16 Oct 2026 Off-label use

A dependable clinic fluid and diluent when 154 mmol/L sodium and chloride, chloride replacement or specific compatibility is wanted. It should be prescribed like a drug, not continued by habit: balanced crystalloids are usually preferable for routine resuscitation, and volume, chloride, sodium and acid-base effects require reassessment.

Regulatory and scientific credibility5.5/10

The exact 0.9% human infusion has a sourced current Georgian registration and identifiable manufacturer, strength and IV route, while exhaustive current checks record it as not registered in EU/EEA, GB or US. Veterinary administration is off-label and no exact-product veterinary dossier was found.

Clinical efficacy6.5/10

Sodium chloride 0.9% reliably expands extracellular volume and supplies sodium and chloride, and it is useful when its composition or compatibility is specifically wanted. It is not physiologically balanced: current dog/cat guidance generally favours buffered balanced crystalloids for routine resuscitation and warns that high chloride exposure may impair acid-base and renal physiology; veterinary comparative outcome evidence remains limited.

Safety and tolerability6.5/10

Class safety is well characterised, but a public exact-product dossier was not found. Main risks are dose- and rate-related fluid overload, hypernatraemia, hyperchloraemia, acid-base disturbance, edema, contamination and line complications; renal, cardiac and oligoanuric patients, cats and small dogs require particularly tight volume control.

Clinical practicality8.5/10

A ready-to-use sterile isotonic solution fits standard IV sets, pumps and drug-dilution workflows and permits weight-based boluses or infusions. Practicality depends on selecting a bag appropriate to patient size, counting flushes and drug carriers in the total fluid prescription, maintaining asepsis, confirming additive compatibility and discarding compromised or time-expired containers.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Do not select 0.9% saline as routine ongoing fluid in existing hypernatraemia or hyperchloraemia. Measure sodium and corrected chloride, define the desired direction and rate of change, and switch or stop when the compositional target is reached.
  • Fluid overload can be life-threatening and is usually iatrogenic. Use extra caution in heart, kidney or liver disease, oliguria/anuria, pulmonary or peripheral edema, cats and small dogs; count every bolus, infusion, flush, drug carrier, enteral input and ongoing loss, and stop non-beneficial fluid.
  • At 154 mmol/L chloride, large or prolonged volumes can raise chloride and contribute to hyperchloraemic metabolic acidosis and possibly renal vasoconstriction. Recheck electrolytes, blood gas/acid-base status, creatinine, urine output and clinical perfusion; use a buffered balanced crystalloid when it better matches the patient.
  • Do not use 0.9% saline automatically as maintenance or free-water replacement. Its sodium and chloride content exceeds maintenance needs, and sodium disorders require a calculated correction plan with frequent reassessment to avoid dangerous neurologic shifts.
  • Before adding or co-infusing any medicine, confirm compatibility, final concentration, diluent, route, stability and line requirements from that medicine’s own current instructions. Inspect for haze, colour change, particles or precipitate; an isotonic carrier is not proof of chemical compatibility.
  • Prescribe a patient-specific endpoint and reassessment interval rather than a fixed universal rate. During resuscitation give measured aliquots and reassess perfusion after each; during ongoing therapy track body weight, respiratory rate/effort, edema, input/output, blood pressure and laboratory trends.
  • Use an intact, clear, particle-free container, a patient-size-appropriate bag and an accurate pump or volume-limiting device. Maintain catheter and port asepsis, follow the exact product’s post-opening limit, never pool residual fluid between patients, and discard a contaminated, damaged or expired container.
  • Pack size, container material, ports, overwrap, storage and post-opening instructions can differ among these eight exact products. The shared score does not imply interchangeability for pressure infusion, drug compounding, blood-line use or a specific delivery device; verify the exact insert before use.
Assessment sources
  1. NaCl 0.9% infusion market audit2026
  2. B. Braun NaCl 0.9% SmPC2023
  3. FDA NaCl 0.9% label2018
  4. AAHA fluid therapy guideline2024
  5. Canine crystalloid comparison2013
  6. Canine/feline hyperchloremia2025
  7. Small-animal fluid overload2021
Assessed: 22 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Sodium chloride9 mg/ml
Formulation Type
Solution
Administration route
Intravenous
Manufacturer
Samarkand England Eco-Medical · Uzbekistan
Registration
Georgia Yes, human
In force until 10 Jun 2027
Human (Ministry of Health, RAMA)
In the register: ნატრიუმის ქლორიდი-SEEM 0.9%, საინფუზიო ხსნარი
№ რ-035499, რ-035500, რ-035501
Verified on: 16 Oct 2026
 EU No
Verified on: 16 Oct 2026
 UK No
Verified on: 16 Oct 2026
 US No
Verified on: 16 Oct 2026
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026

Sodium Chloride Aculife 0.9%, Solution

solution for infusion, human medicine
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog Selected IV 0.9% sodium chloride for extracellular-volume replacement, chloride-responsive metabolic alkalosis, or a compatible injectable-drug diluent/flush; not default maintenance, free-water replacement or routine resuscitation fluid
6.6/10
Situational / acceptable
vetman assessment

Sodium Chloride Aculife

0.9%, solution for infusion, human medicine
Assessed clinical scopeDog · Selected IV 0.9% sodium chloride for extracellular-volume replacement, chloride-responsive metabolic alkalosis, or a compatible injectable-drug diluent/flush; not default maintenance, free-water replacement or routine resuscitation fluid · Intravenous
Care settingVeterinary clinic or hospital after individual fluid prescription, using a pump or other volume-limiting device and repeated perfusion, body-weight, input/output, electrolyte and acid-base reassessment
vetman score 6.6/10 Situational / acceptable
Evidence confidence: Medium Georgia: Yes, human · № რ-034287, რ-034289, რ-034291, რ-034293 · Verified on 16 Oct 2026 Off-label use

A dependable clinic fluid and diluent when 154 mmol/L sodium and chloride, chloride replacement or specific compatibility is wanted. It should be prescribed like a drug, not continued by habit: balanced crystalloids are usually preferable for routine resuscitation, and volume, chloride, sodium and acid-base effects require reassessment.

Regulatory and scientific credibility5.5/10

The exact 0.9% human infusion has a sourced current Georgian registration and identifiable manufacturer, strength and IV route, while exhaustive current checks record it as not registered in EU/EEA, GB or US. Veterinary administration is off-label and no exact-product veterinary dossier was found.

Clinical efficacy6.5/10

Sodium chloride 0.9% reliably expands extracellular volume and supplies sodium and chloride, and it is useful when its composition or compatibility is specifically wanted. It is not physiologically balanced: current dog/cat guidance generally favours buffered balanced crystalloids for routine resuscitation and warns that high chloride exposure may impair acid-base and renal physiology; veterinary comparative outcome evidence remains limited.

Safety and tolerability6.5/10

Class safety is well characterised, but a public exact-product dossier was not found. Main risks are dose- and rate-related fluid overload, hypernatraemia, hyperchloraemia, acid-base disturbance, edema, contamination and line complications; renal, cardiac and oligoanuric patients, cats and small dogs require particularly tight volume control.

Clinical practicality8.5/10

A ready-to-use sterile isotonic solution fits standard IV sets, pumps and drug-dilution workflows and permits weight-based boluses or infusions. Practicality depends on selecting a bag appropriate to patient size, counting flushes and drug carriers in the total fluid prescription, maintaining asepsis, confirming additive compatibility and discarding compromised or time-expired containers.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Do not select 0.9% saline as routine ongoing fluid in existing hypernatraemia or hyperchloraemia. Measure sodium and corrected chloride, define the desired direction and rate of change, and switch or stop when the compositional target is reached.
  • Fluid overload can be life-threatening and is usually iatrogenic. Use extra caution in heart, kidney or liver disease, oliguria/anuria, pulmonary or peripheral edema, cats and small dogs; count every bolus, infusion, flush, drug carrier, enteral input and ongoing loss, and stop non-beneficial fluid.
  • At 154 mmol/L chloride, large or prolonged volumes can raise chloride and contribute to hyperchloraemic metabolic acidosis and possibly renal vasoconstriction. Recheck electrolytes, blood gas/acid-base status, creatinine, urine output and clinical perfusion; use a buffered balanced crystalloid when it better matches the patient.
  • Do not use 0.9% saline automatically as maintenance or free-water replacement. Its sodium and chloride content exceeds maintenance needs, and sodium disorders require a calculated correction plan with frequent reassessment to avoid dangerous neurologic shifts.
  • Before adding or co-infusing any medicine, confirm compatibility, final concentration, diluent, route, stability and line requirements from that medicine’s own current instructions. Inspect for haze, colour change, particles or precipitate; an isotonic carrier is not proof of chemical compatibility.
  • Prescribe a patient-specific endpoint and reassessment interval rather than a fixed universal rate. During resuscitation give measured aliquots and reassess perfusion after each; during ongoing therapy track body weight, respiratory rate/effort, edema, input/output, blood pressure and laboratory trends.
  • Use an intact, clear, particle-free container, a patient-size-appropriate bag and an accurate pump or volume-limiting device. Maintain catheter and port asepsis, follow the exact product’s post-opening limit, never pool residual fluid between patients, and discard a contaminated, damaged or expired container.
  • Pack size, container material, ports, overwrap, storage and post-opening instructions can differ among these eight exact products. The shared score does not imply interchangeability for pressure infusion, drug compounding, blood-line use or a specific delivery device; verify the exact insert before use.
Assessment sources
  1. NaCl 0.9% infusion market audit2026
  2. B. Braun NaCl 0.9% SmPC2023
  3. FDA NaCl 0.9% label2018
  4. AAHA fluid therapy guideline2024
  5. Canine crystalloid comparison2013
  6. Canine/feline hyperchloremia2025
  7. Small-animal fluid overload2021
Assessed: 22 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Cat Selected IV 0.9% sodium chloride for extracellular-volume replacement, chloride-responsive metabolic alkalosis, or a compatible injectable-drug diluent/flush; not default maintenance, free-water replacement or routine resuscitation fluid
6.6/10
Situational / acceptable
vetman assessment

Sodium Chloride Aculife

0.9%, solution for infusion, human medicine
Assessed clinical scopeCat · Selected IV 0.9% sodium chloride for extracellular-volume replacement, chloride-responsive metabolic alkalosis, or a compatible injectable-drug diluent/flush; not default maintenance, free-water replacement or routine resuscitation fluid · Intravenous
Care settingVeterinary clinic or hospital after individual fluid prescription, using a pump or other volume-limiting device and repeated perfusion, body-weight, input/output, electrolyte and acid-base reassessment
vetman score 6.6/10 Situational / acceptable
Evidence confidence: Medium Georgia: Yes, human · № რ-034287, რ-034289, რ-034291, რ-034293 · Verified on 16 Oct 2026 Off-label use

A dependable clinic fluid and diluent when 154 mmol/L sodium and chloride, chloride replacement or specific compatibility is wanted. It should be prescribed like a drug, not continued by habit: balanced crystalloids are usually preferable for routine resuscitation, and volume, chloride, sodium and acid-base effects require reassessment.

Regulatory and scientific credibility5.5/10

The exact 0.9% human infusion has a sourced current Georgian registration and identifiable manufacturer, strength and IV route, while exhaustive current checks record it as not registered in EU/EEA, GB or US. Veterinary administration is off-label and no exact-product veterinary dossier was found.

Clinical efficacy6.5/10

Sodium chloride 0.9% reliably expands extracellular volume and supplies sodium and chloride, and it is useful when its composition or compatibility is specifically wanted. It is not physiologically balanced: current dog/cat guidance generally favours buffered balanced crystalloids for routine resuscitation and warns that high chloride exposure may impair acid-base and renal physiology; veterinary comparative outcome evidence remains limited.

Safety and tolerability6.5/10

Class safety is well characterised, but a public exact-product dossier was not found. Main risks are dose- and rate-related fluid overload, hypernatraemia, hyperchloraemia, acid-base disturbance, edema, contamination and line complications; renal, cardiac and oligoanuric patients, cats and small dogs require particularly tight volume control.

Clinical practicality8.5/10

A ready-to-use sterile isotonic solution fits standard IV sets, pumps and drug-dilution workflows and permits weight-based boluses or infusions. Practicality depends on selecting a bag appropriate to patient size, counting flushes and drug carriers in the total fluid prescription, maintaining asepsis, confirming additive compatibility and discarding compromised or time-expired containers.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Do not select 0.9% saline as routine ongoing fluid in existing hypernatraemia or hyperchloraemia. Measure sodium and corrected chloride, define the desired direction and rate of change, and switch or stop when the compositional target is reached.
  • Fluid overload can be life-threatening and is usually iatrogenic. Use extra caution in heart, kidney or liver disease, oliguria/anuria, pulmonary or peripheral edema, cats and small dogs; count every bolus, infusion, flush, drug carrier, enteral input and ongoing loss, and stop non-beneficial fluid.
  • At 154 mmol/L chloride, large or prolonged volumes can raise chloride and contribute to hyperchloraemic metabolic acidosis and possibly renal vasoconstriction. Recheck electrolytes, blood gas/acid-base status, creatinine, urine output and clinical perfusion; use a buffered balanced crystalloid when it better matches the patient.
  • Do not use 0.9% saline automatically as maintenance or free-water replacement. Its sodium and chloride content exceeds maintenance needs, and sodium disorders require a calculated correction plan with frequent reassessment to avoid dangerous neurologic shifts.
  • Before adding or co-infusing any medicine, confirm compatibility, final concentration, diluent, route, stability and line requirements from that medicine’s own current instructions. Inspect for haze, colour change, particles or precipitate; an isotonic carrier is not proof of chemical compatibility.
  • Prescribe a patient-specific endpoint and reassessment interval rather than a fixed universal rate. During resuscitation give measured aliquots and reassess perfusion after each; during ongoing therapy track body weight, respiratory rate/effort, edema, input/output, blood pressure and laboratory trends.
  • Use an intact, clear, particle-free container, a patient-size-appropriate bag and an accurate pump or volume-limiting device. Maintain catheter and port asepsis, follow the exact product’s post-opening limit, never pool residual fluid between patients, and discard a contaminated, damaged or expired container.
  • Pack size, container material, ports, overwrap, storage and post-opening instructions can differ among these eight exact products. The shared score does not imply interchangeability for pressure infusion, drug compounding, blood-line use or a specific delivery device; verify the exact insert before use.
Assessment sources
  1. NaCl 0.9% infusion market audit2026
  2. B. Braun NaCl 0.9% SmPC2023
  3. FDA NaCl 0.9% label2018
  4. AAHA fluid therapy guideline2024
  5. Canine crystalloid comparison2013
  6. Canine/feline hyperchloremia2025
  7. Small-animal fluid overload2021
Assessed: 22 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Sodium chloride9 mg/ml
Formulation Type
Solution
Administration route
Intravenous
Manufacturer
Aculife Healthcare · India
Registration
Georgia Yes, human
In force until 28 Jan 2027
Human (Ministry of Health, RAMA)
In the register: ნატრიუმის ქლორიდი აკულაიფი 0.9%, საინფუზიო ხსნარი
№ რ-034287, რ-034289, რ-034291, რ-034293
Verified on: 16 Oct 2026
 EU No
Verified on: 16 Oct 2026
 UK No
Verified on: 16 Oct 2026
 US No
Verified on: 16 Oct 2026
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026

Sodium Chloride Braun 0.9%, Solution

solution for infusion, human medicine
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog Selected IV 0.9% sodium chloride for extracellular-volume replacement, chloride-responsive metabolic alkalosis, or a compatible injectable-drug diluent/flush; not default maintenance, free-water replacement or routine resuscitation fluid
7.3/10
Good
vetman assessment

Sodium Chloride Braun

0.9%, solution for infusion, human medicine
Assessed clinical scopeDog · Selected IV 0.9% sodium chloride for extracellular-volume replacement, chloride-responsive metabolic alkalosis, or a compatible injectable-drug diluent/flush; not default maintenance, free-water replacement or routine resuscitation fluid · Intravenous
Care settingVeterinary clinic or hospital after individual fluid prescription, using a pump or other volume-limiting device and repeated perfusion, body-weight, input/output, electrolyte and acid-base reassessment
vetman score 7.3/10 Good
Evidence confidence: Medium Georgia: Yes, human · № რ-043951, რ-043952 · Verified on 16 Oct 2026 Off-label use

A dependable clinic fluid and diluent when 154 mmol/L sodium and chloride, chloride replacement or specific compatibility is wanted. It should be prescribed like a drug, not continued by habit: balanced crystalloids are usually preferable for routine resuscitation, and volume, chloride, sodium and acid-base effects require reassessment.

Regulatory and scientific credibility7.5/10

This exact B. Braun 0.9% presentation has sourced current Georgian, EU/EEA, GB and US market records and an accessible composition, handling and safety dossier. Veterinary administration remains off-label and the human product dossier does not establish an animal-specific claim.

Clinical efficacy6.5/10

Sodium chloride 0.9% reliably expands extracellular volume and supplies sodium and chloride, and it is useful when its composition or compatibility is specifically wanted. It is not physiologically balanced: current dog/cat guidance generally favours buffered balanced crystalloids for routine resuscitation and warns that high chloride exposure may impair acid-base and renal physiology; veterinary comparative outcome evidence remains limited.

Safety and tolerability7.0/10

The exact transparent SmPC and extensive class experience make the major risks predictable: dose- and rate-related fluid overload, hypernatraemia, hyperchloraemia, acid-base disturbance, edema and line-related complications. Correct selection, asepsis, volume control and serial monitoring give a reasonable margin, but renal, cardiac and oligoanuric patients can decompensate with small excess volumes.

Clinical practicality8.5/10

A ready-to-use sterile isotonic solution fits standard IV sets, pumps and drug-dilution workflows and permits weight-based boluses or infusions. Practicality depends on selecting a bag appropriate to patient size, counting flushes and drug carriers in the total fluid prescription, maintaining asepsis, confirming additive compatibility and discarding compromised or time-expired containers.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Do not select 0.9% saline as routine ongoing fluid in existing hypernatraemia or hyperchloraemia. Measure sodium and corrected chloride, define the desired direction and rate of change, and switch or stop when the compositional target is reached.
  • Fluid overload can be life-threatening and is usually iatrogenic. Use extra caution in heart, kidney or liver disease, oliguria/anuria, pulmonary or peripheral edema, cats and small dogs; count every bolus, infusion, flush, drug carrier, enteral input and ongoing loss, and stop non-beneficial fluid.
  • At 154 mmol/L chloride, large or prolonged volumes can raise chloride and contribute to hyperchloraemic metabolic acidosis and possibly renal vasoconstriction. Recheck electrolytes, blood gas/acid-base status, creatinine, urine output and clinical perfusion; use a buffered balanced crystalloid when it better matches the patient.
  • Do not use 0.9% saline automatically as maintenance or free-water replacement. Its sodium and chloride content exceeds maintenance needs, and sodium disorders require a calculated correction plan with frequent reassessment to avoid dangerous neurologic shifts.
  • Before adding or co-infusing any medicine, confirm compatibility, final concentration, diluent, route, stability and line requirements from that medicine’s own current instructions. Inspect for haze, colour change, particles or precipitate; an isotonic carrier is not proof of chemical compatibility.
  • Prescribe a patient-specific endpoint and reassessment interval rather than a fixed universal rate. During resuscitation give measured aliquots and reassess perfusion after each; during ongoing therapy track body weight, respiratory rate/effort, edema, input/output, blood pressure and laboratory trends.
  • Use an intact, clear, particle-free container, a patient-size-appropriate bag and an accurate pump or volume-limiting device. Maintain catheter and port asepsis, follow the exact product’s post-opening limit, never pool residual fluid between patients, and discard a contaminated, damaged or expired container.
  • Pack size, container material, ports, overwrap, storage and post-opening instructions can differ among these eight exact products. The shared score does not imply interchangeability for pressure infusion, drug compounding, blood-line use or a specific delivery device; verify the exact insert before use.
Assessment sources
  1. NaCl 0.9% infusion market audit2026
  2. B. Braun NaCl 0.9% SmPC2023
  3. FDA NaCl 0.9% label2018
  4. AAHA fluid therapy guideline2024
  5. Canine crystalloid comparison2013
  6. Canine/feline hyperchloremia2025
  7. Small-animal fluid overload2021
Assessed: 22 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Cat Selected IV 0.9% sodium chloride for extracellular-volume replacement, chloride-responsive metabolic alkalosis, or a compatible injectable-drug diluent/flush; not default maintenance, free-water replacement or routine resuscitation fluid
7.3/10
Good
vetman assessment

Sodium Chloride Braun

0.9%, solution for infusion, human medicine
Assessed clinical scopeCat · Selected IV 0.9% sodium chloride for extracellular-volume replacement, chloride-responsive metabolic alkalosis, or a compatible injectable-drug diluent/flush; not default maintenance, free-water replacement or routine resuscitation fluid · Intravenous
Care settingVeterinary clinic or hospital after individual fluid prescription, using a pump or other volume-limiting device and repeated perfusion, body-weight, input/output, electrolyte and acid-base reassessment
vetman score 7.3/10 Good
Evidence confidence: Medium Georgia: Yes, human · № რ-043951, რ-043952 · Verified on 16 Oct 2026 Off-label use

A dependable clinic fluid and diluent when 154 mmol/L sodium and chloride, chloride replacement or specific compatibility is wanted. It should be prescribed like a drug, not continued by habit: balanced crystalloids are usually preferable for routine resuscitation, and volume, chloride, sodium and acid-base effects require reassessment.

Regulatory and scientific credibility7.5/10

This exact B. Braun 0.9% presentation has sourced current Georgian, EU/EEA, GB and US market records and an accessible composition, handling and safety dossier. Veterinary administration remains off-label and the human product dossier does not establish an animal-specific claim.

Clinical efficacy6.5/10

Sodium chloride 0.9% reliably expands extracellular volume and supplies sodium and chloride, and it is useful when its composition or compatibility is specifically wanted. It is not physiologically balanced: current dog/cat guidance generally favours buffered balanced crystalloids for routine resuscitation and warns that high chloride exposure may impair acid-base and renal physiology; veterinary comparative outcome evidence remains limited.

Safety and tolerability7.0/10

The exact transparent SmPC and extensive class experience make the major risks predictable: dose- and rate-related fluid overload, hypernatraemia, hyperchloraemia, acid-base disturbance, edema and line-related complications. Correct selection, asepsis, volume control and serial monitoring give a reasonable margin, but renal, cardiac and oligoanuric patients can decompensate with small excess volumes.

Clinical practicality8.5/10

A ready-to-use sterile isotonic solution fits standard IV sets, pumps and drug-dilution workflows and permits weight-based boluses or infusions. Practicality depends on selecting a bag appropriate to patient size, counting flushes and drug carriers in the total fluid prescription, maintaining asepsis, confirming additive compatibility and discarding compromised or time-expired containers.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Do not select 0.9% saline as routine ongoing fluid in existing hypernatraemia or hyperchloraemia. Measure sodium and corrected chloride, define the desired direction and rate of change, and switch or stop when the compositional target is reached.
  • Fluid overload can be life-threatening and is usually iatrogenic. Use extra caution in heart, kidney or liver disease, oliguria/anuria, pulmonary or peripheral edema, cats and small dogs; count every bolus, infusion, flush, drug carrier, enteral input and ongoing loss, and stop non-beneficial fluid.
  • At 154 mmol/L chloride, large or prolonged volumes can raise chloride and contribute to hyperchloraemic metabolic acidosis and possibly renal vasoconstriction. Recheck electrolytes, blood gas/acid-base status, creatinine, urine output and clinical perfusion; use a buffered balanced crystalloid when it better matches the patient.
  • Do not use 0.9% saline automatically as maintenance or free-water replacement. Its sodium and chloride content exceeds maintenance needs, and sodium disorders require a calculated correction plan with frequent reassessment to avoid dangerous neurologic shifts.
  • Before adding or co-infusing any medicine, confirm compatibility, final concentration, diluent, route, stability and line requirements from that medicine’s own current instructions. Inspect for haze, colour change, particles or precipitate; an isotonic carrier is not proof of chemical compatibility.
  • Prescribe a patient-specific endpoint and reassessment interval rather than a fixed universal rate. During resuscitation give measured aliquots and reassess perfusion after each; during ongoing therapy track body weight, respiratory rate/effort, edema, input/output, blood pressure and laboratory trends.
  • Use an intact, clear, particle-free container, a patient-size-appropriate bag and an accurate pump or volume-limiting device. Maintain catheter and port asepsis, follow the exact product’s post-opening limit, never pool residual fluid between patients, and discard a contaminated, damaged or expired container.
  • Pack size, container material, ports, overwrap, storage and post-opening instructions can differ among these eight exact products. The shared score does not imply interchangeability for pressure infusion, drug compounding, blood-line use or a specific delivery device; verify the exact insert before use.
Assessment sources
  1. NaCl 0.9% infusion market audit2026
  2. B. Braun NaCl 0.9% SmPC2023
  3. FDA NaCl 0.9% label2018
  4. AAHA fluid therapy guideline2024
  5. Canine crystalloid comparison2013
  6. Canine/feline hyperchloremia2025
  7. Small-animal fluid overload2021
Assessed: 22 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Sodium chloride9 mg/ml
Formulation Type
Solution
Administration route
Intravenous
Manufacturer
B. Braun Melsungen · Germany
Registration
Georgia Yes, human
In force until 04 Sep 2030
Human (Ministry of Health, RAMA)
In the register: ნატრიუმის ქლორიდი ბრაუნი 0.9%, საინფუზიო ხსნარი
№ რ-043951, რ-043952
Verified on: 16 Oct 2026
 EU Yes, human
Verified on: 16 Oct 2026
 UK Yes, human
№ PL035510069, PL035510076, PL035510079, PL035510082
Verified on: 16 Oct 2026
 US Yes, human
№ ANDA091387, NDA016733, NDA017464
Verified on: 16 Oct 2026
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026

Sodium Chloride Dentafill Plus 0.9%, Solution

solution for infusion, human medicine
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog Selected IV 0.9% sodium chloride for extracellular-volume replacement, chloride-responsive metabolic alkalosis, or a compatible injectable-drug diluent/flush; not default maintenance, free-water replacement or routine resuscitation fluid
6.6/10
Situational / acceptable
vetman assessment

Sodium Chloride Dentafill Plus

0.9%, solution for infusion, human medicine
Assessed clinical scopeDog · Selected IV 0.9% sodium chloride for extracellular-volume replacement, chloride-responsive metabolic alkalosis, or a compatible injectable-drug diluent/flush; not default maintenance, free-water replacement or routine resuscitation fluid · Intravenous
Care settingVeterinary clinic or hospital after individual fluid prescription, using a pump or other volume-limiting device and repeated perfusion, body-weight, input/output, electrolyte and acid-base reassessment
vetman score 6.6/10 Situational / acceptable
Evidence confidence: Medium Georgia: Yes, human · № რ-035729, რ-035730, რ-035731 · Verified on 16 Oct 2026 Off-label use

A dependable clinic fluid and diluent when 154 mmol/L sodium and chloride, chloride replacement or specific compatibility is wanted. It should be prescribed like a drug, not continued by habit: balanced crystalloids are usually preferable for routine resuscitation, and volume, chloride, sodium and acid-base effects require reassessment.

Regulatory and scientific credibility5.5/10

The exact 0.9% human infusion has a sourced current Georgian registration and identifiable manufacturer, strength and IV route, while exhaustive current checks record it as not registered in EU/EEA, GB or US. Veterinary administration is off-label and no exact-product veterinary dossier was found.

Clinical efficacy6.5/10

Sodium chloride 0.9% reliably expands extracellular volume and supplies sodium and chloride, and it is useful when its composition or compatibility is specifically wanted. It is not physiologically balanced: current dog/cat guidance generally favours buffered balanced crystalloids for routine resuscitation and warns that high chloride exposure may impair acid-base and renal physiology; veterinary comparative outcome evidence remains limited.

Safety and tolerability6.5/10

Class safety is well characterised, but a public exact-product dossier was not found. Main risks are dose- and rate-related fluid overload, hypernatraemia, hyperchloraemia, acid-base disturbance, edema, contamination and line complications; renal, cardiac and oligoanuric patients, cats and small dogs require particularly tight volume control.

Clinical practicality8.5/10

A ready-to-use sterile isotonic solution fits standard IV sets, pumps and drug-dilution workflows and permits weight-based boluses or infusions. Practicality depends on selecting a bag appropriate to patient size, counting flushes and drug carriers in the total fluid prescription, maintaining asepsis, confirming additive compatibility and discarding compromised or time-expired containers.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Do not select 0.9% saline as routine ongoing fluid in existing hypernatraemia or hyperchloraemia. Measure sodium and corrected chloride, define the desired direction and rate of change, and switch or stop when the compositional target is reached.
  • Fluid overload can be life-threatening and is usually iatrogenic. Use extra caution in heart, kidney or liver disease, oliguria/anuria, pulmonary or peripheral edema, cats and small dogs; count every bolus, infusion, flush, drug carrier, enteral input and ongoing loss, and stop non-beneficial fluid.
  • At 154 mmol/L chloride, large or prolonged volumes can raise chloride and contribute to hyperchloraemic metabolic acidosis and possibly renal vasoconstriction. Recheck electrolytes, blood gas/acid-base status, creatinine, urine output and clinical perfusion; use a buffered balanced crystalloid when it better matches the patient.
  • Do not use 0.9% saline automatically as maintenance or free-water replacement. Its sodium and chloride content exceeds maintenance needs, and sodium disorders require a calculated correction plan with frequent reassessment to avoid dangerous neurologic shifts.
  • Before adding or co-infusing any medicine, confirm compatibility, final concentration, diluent, route, stability and line requirements from that medicine’s own current instructions. Inspect for haze, colour change, particles or precipitate; an isotonic carrier is not proof of chemical compatibility.
  • Prescribe a patient-specific endpoint and reassessment interval rather than a fixed universal rate. During resuscitation give measured aliquots and reassess perfusion after each; during ongoing therapy track body weight, respiratory rate/effort, edema, input/output, blood pressure and laboratory trends.
  • Use an intact, clear, particle-free container, a patient-size-appropriate bag and an accurate pump or volume-limiting device. Maintain catheter and port asepsis, follow the exact product’s post-opening limit, never pool residual fluid between patients, and discard a contaminated, damaged or expired container.
  • Pack size, container material, ports, overwrap, storage and post-opening instructions can differ among these eight exact products. The shared score does not imply interchangeability for pressure infusion, drug compounding, blood-line use or a specific delivery device; verify the exact insert before use.
Assessment sources
  1. NaCl 0.9% infusion market audit2026
  2. B. Braun NaCl 0.9% SmPC2023
  3. FDA NaCl 0.9% label2018
  4. AAHA fluid therapy guideline2024
  5. Canine crystalloid comparison2013
  6. Canine/feline hyperchloremia2025
  7. Small-animal fluid overload2021
Assessed: 22 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Cat Selected IV 0.9% sodium chloride for extracellular-volume replacement, chloride-responsive metabolic alkalosis, or a compatible injectable-drug diluent/flush; not default maintenance, free-water replacement or routine resuscitation fluid
6.6/10
Situational / acceptable
vetman assessment

Sodium Chloride Dentafill Plus

0.9%, solution for infusion, human medicine
Assessed clinical scopeCat · Selected IV 0.9% sodium chloride for extracellular-volume replacement, chloride-responsive metabolic alkalosis, or a compatible injectable-drug diluent/flush; not default maintenance, free-water replacement or routine resuscitation fluid · Intravenous
Care settingVeterinary clinic or hospital after individual fluid prescription, using a pump or other volume-limiting device and repeated perfusion, body-weight, input/output, electrolyte and acid-base reassessment
vetman score 6.6/10 Situational / acceptable
Evidence confidence: Medium Georgia: Yes, human · № რ-035729, რ-035730, რ-035731 · Verified on 16 Oct 2026 Off-label use

A dependable clinic fluid and diluent when 154 mmol/L sodium and chloride, chloride replacement or specific compatibility is wanted. It should be prescribed like a drug, not continued by habit: balanced crystalloids are usually preferable for routine resuscitation, and volume, chloride, sodium and acid-base effects require reassessment.

Regulatory and scientific credibility5.5/10

The exact 0.9% human infusion has a sourced current Georgian registration and identifiable manufacturer, strength and IV route, while exhaustive current checks record it as not registered in EU/EEA, GB or US. Veterinary administration is off-label and no exact-product veterinary dossier was found.

Clinical efficacy6.5/10

Sodium chloride 0.9% reliably expands extracellular volume and supplies sodium and chloride, and it is useful when its composition or compatibility is specifically wanted. It is not physiologically balanced: current dog/cat guidance generally favours buffered balanced crystalloids for routine resuscitation and warns that high chloride exposure may impair acid-base and renal physiology; veterinary comparative outcome evidence remains limited.

Safety and tolerability6.5/10

Class safety is well characterised, but a public exact-product dossier was not found. Main risks are dose- and rate-related fluid overload, hypernatraemia, hyperchloraemia, acid-base disturbance, edema, contamination and line complications; renal, cardiac and oligoanuric patients, cats and small dogs require particularly tight volume control.

Clinical practicality8.5/10

A ready-to-use sterile isotonic solution fits standard IV sets, pumps and drug-dilution workflows and permits weight-based boluses or infusions. Practicality depends on selecting a bag appropriate to patient size, counting flushes and drug carriers in the total fluid prescription, maintaining asepsis, confirming additive compatibility and discarding compromised or time-expired containers.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Do not select 0.9% saline as routine ongoing fluid in existing hypernatraemia or hyperchloraemia. Measure sodium and corrected chloride, define the desired direction and rate of change, and switch or stop when the compositional target is reached.
  • Fluid overload can be life-threatening and is usually iatrogenic. Use extra caution in heart, kidney or liver disease, oliguria/anuria, pulmonary or peripheral edema, cats and small dogs; count every bolus, infusion, flush, drug carrier, enteral input and ongoing loss, and stop non-beneficial fluid.
  • At 154 mmol/L chloride, large or prolonged volumes can raise chloride and contribute to hyperchloraemic metabolic acidosis and possibly renal vasoconstriction. Recheck electrolytes, blood gas/acid-base status, creatinine, urine output and clinical perfusion; use a buffered balanced crystalloid when it better matches the patient.
  • Do not use 0.9% saline automatically as maintenance or free-water replacement. Its sodium and chloride content exceeds maintenance needs, and sodium disorders require a calculated correction plan with frequent reassessment to avoid dangerous neurologic shifts.
  • Before adding or co-infusing any medicine, confirm compatibility, final concentration, diluent, route, stability and line requirements from that medicine’s own current instructions. Inspect for haze, colour change, particles or precipitate; an isotonic carrier is not proof of chemical compatibility.
  • Prescribe a patient-specific endpoint and reassessment interval rather than a fixed universal rate. During resuscitation give measured aliquots and reassess perfusion after each; during ongoing therapy track body weight, respiratory rate/effort, edema, input/output, blood pressure and laboratory trends.
  • Use an intact, clear, particle-free container, a patient-size-appropriate bag and an accurate pump or volume-limiting device. Maintain catheter and port asepsis, follow the exact product’s post-opening limit, never pool residual fluid between patients, and discard a contaminated, damaged or expired container.
  • Pack size, container material, ports, overwrap, storage and post-opening instructions can differ among these eight exact products. The shared score does not imply interchangeability for pressure infusion, drug compounding, blood-line use or a specific delivery device; verify the exact insert before use.
Assessment sources
  1. NaCl 0.9% infusion market audit2026
  2. B. Braun NaCl 0.9% SmPC2023
  3. FDA NaCl 0.9% label2018
  4. AAHA fluid therapy guideline2024
  5. Canine crystalloid comparison2013
  6. Canine/feline hyperchloremia2025
  7. Small-animal fluid overload2021
Assessed: 22 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Sodium chloride9 mg/ml
Formulation Type
Solution
Administration route
Intravenous
Manufacturer
Dentafill Plus · Uzbekistan
Registration
Georgia Yes, human
In force until 01 Jul 2027
Human (Ministry of Health, RAMA)
In the register: ნატრიუმის ქლორიდი დენტაფილ პლუსი 0.9%, საინფუზიო ხსნარი
№ რ-035729, რ-035730, რ-035731
Verified on: 16 Oct 2026
 EU No
Verified on: 16 Oct 2026
 UK No
Verified on: 16 Oct 2026
 US No
Verified on: 16 Oct 2026
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026

Sodium Chloride Liqvor 0.9%, Solution

solution for infusion, human medicine
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog Selected IV 0.9% sodium chloride for extracellular-volume replacement, chloride-responsive metabolic alkalosis, or a compatible injectable-drug diluent/flush; not default maintenance, free-water replacement or routine resuscitation fluid
6.6/10
Situational / acceptable
vetman assessment

Sodium Chloride Liqvor

0.9%, solution for infusion, human medicine
Assessed clinical scopeDog · Selected IV 0.9% sodium chloride for extracellular-volume replacement, chloride-responsive metabolic alkalosis, or a compatible injectable-drug diluent/flush; not default maintenance, free-water replacement or routine resuscitation fluid · Intravenous
Care settingVeterinary clinic or hospital after individual fluid prescription, using a pump or other volume-limiting device and repeated perfusion, body-weight, input/output, electrolyte and acid-base reassessment
vetman score 6.6/10 Situational / acceptable
Evidence confidence: Medium Georgia: Yes, human · № რ-038724, რ-038725, რ-038726, რ-038727 · Verified on 16 Oct 2026 Off-label use

A dependable clinic fluid and diluent when 154 mmol/L sodium and chloride, chloride replacement or specific compatibility is wanted. It should be prescribed like a drug, not continued by habit: balanced crystalloids are usually preferable for routine resuscitation, and volume, chloride, sodium and acid-base effects require reassessment.

Regulatory and scientific credibility5.5/10

The exact 0.9% human infusion has a sourced current Georgian registration and identifiable manufacturer, strength and IV route, while exhaustive current checks record it as not registered in EU/EEA, GB or US. Veterinary administration is off-label and no exact-product veterinary dossier was found.

Clinical efficacy6.5/10

Sodium chloride 0.9% reliably expands extracellular volume and supplies sodium and chloride, and it is useful when its composition or compatibility is specifically wanted. It is not physiologically balanced: current dog/cat guidance generally favours buffered balanced crystalloids for routine resuscitation and warns that high chloride exposure may impair acid-base and renal physiology; veterinary comparative outcome evidence remains limited.

Safety and tolerability6.5/10

Class safety is well characterised, but a public exact-product dossier was not found. Main risks are dose- and rate-related fluid overload, hypernatraemia, hyperchloraemia, acid-base disturbance, edema, contamination and line complications; renal, cardiac and oligoanuric patients, cats and small dogs require particularly tight volume control.

Clinical practicality8.5/10

A ready-to-use sterile isotonic solution fits standard IV sets, pumps and drug-dilution workflows and permits weight-based boluses or infusions. Practicality depends on selecting a bag appropriate to patient size, counting flushes and drug carriers in the total fluid prescription, maintaining asepsis, confirming additive compatibility and discarding compromised or time-expired containers.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Do not select 0.9% saline as routine ongoing fluid in existing hypernatraemia or hyperchloraemia. Measure sodium and corrected chloride, define the desired direction and rate of change, and switch or stop when the compositional target is reached.
  • Fluid overload can be life-threatening and is usually iatrogenic. Use extra caution in heart, kidney or liver disease, oliguria/anuria, pulmonary or peripheral edema, cats and small dogs; count every bolus, infusion, flush, drug carrier, enteral input and ongoing loss, and stop non-beneficial fluid.
  • At 154 mmol/L chloride, large or prolonged volumes can raise chloride and contribute to hyperchloraemic metabolic acidosis and possibly renal vasoconstriction. Recheck electrolytes, blood gas/acid-base status, creatinine, urine output and clinical perfusion; use a buffered balanced crystalloid when it better matches the patient.
  • Do not use 0.9% saline automatically as maintenance or free-water replacement. Its sodium and chloride content exceeds maintenance needs, and sodium disorders require a calculated correction plan with frequent reassessment to avoid dangerous neurologic shifts.
  • Before adding or co-infusing any medicine, confirm compatibility, final concentration, diluent, route, stability and line requirements from that medicine’s own current instructions. Inspect for haze, colour change, particles or precipitate; an isotonic carrier is not proof of chemical compatibility.
  • Prescribe a patient-specific endpoint and reassessment interval rather than a fixed universal rate. During resuscitation give measured aliquots and reassess perfusion after each; during ongoing therapy track body weight, respiratory rate/effort, edema, input/output, blood pressure and laboratory trends.
  • Use an intact, clear, particle-free container, a patient-size-appropriate bag and an accurate pump or volume-limiting device. Maintain catheter and port asepsis, follow the exact product’s post-opening limit, never pool residual fluid between patients, and discard a contaminated, damaged or expired container.
  • Pack size, container material, ports, overwrap, storage and post-opening instructions can differ among these eight exact products. The shared score does not imply interchangeability for pressure infusion, drug compounding, blood-line use or a specific delivery device; verify the exact insert before use.
Assessment sources
  1. NaCl 0.9% infusion market audit2026
  2. B. Braun NaCl 0.9% SmPC2023
  3. FDA NaCl 0.9% label2018
  4. AAHA fluid therapy guideline2024
  5. Canine crystalloid comparison2013
  6. Canine/feline hyperchloremia2025
  7. Small-animal fluid overload2021
Assessed: 22 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Cat Selected IV 0.9% sodium chloride for extracellular-volume replacement, chloride-responsive metabolic alkalosis, or a compatible injectable-drug diluent/flush; not default maintenance, free-water replacement or routine resuscitation fluid
6.6/10
Situational / acceptable
vetman assessment

Sodium Chloride Liqvor

0.9%, solution for infusion, human medicine
Assessed clinical scopeCat · Selected IV 0.9% sodium chloride for extracellular-volume replacement, chloride-responsive metabolic alkalosis, or a compatible injectable-drug diluent/flush; not default maintenance, free-water replacement or routine resuscitation fluid · Intravenous
Care settingVeterinary clinic or hospital after individual fluid prescription, using a pump or other volume-limiting device and repeated perfusion, body-weight, input/output, electrolyte and acid-base reassessment
vetman score 6.6/10 Situational / acceptable
Evidence confidence: Medium Georgia: Yes, human · № რ-038724, რ-038725, რ-038726, რ-038727 · Verified on 16 Oct 2026 Off-label use

A dependable clinic fluid and diluent when 154 mmol/L sodium and chloride, chloride replacement or specific compatibility is wanted. It should be prescribed like a drug, not continued by habit: balanced crystalloids are usually preferable for routine resuscitation, and volume, chloride, sodium and acid-base effects require reassessment.

Regulatory and scientific credibility5.5/10

The exact 0.9% human infusion has a sourced current Georgian registration and identifiable manufacturer, strength and IV route, while exhaustive current checks record it as not registered in EU/EEA, GB or US. Veterinary administration is off-label and no exact-product veterinary dossier was found.

Clinical efficacy6.5/10

Sodium chloride 0.9% reliably expands extracellular volume and supplies sodium and chloride, and it is useful when its composition or compatibility is specifically wanted. It is not physiologically balanced: current dog/cat guidance generally favours buffered balanced crystalloids for routine resuscitation and warns that high chloride exposure may impair acid-base and renal physiology; veterinary comparative outcome evidence remains limited.

Safety and tolerability6.5/10

Class safety is well characterised, but a public exact-product dossier was not found. Main risks are dose- and rate-related fluid overload, hypernatraemia, hyperchloraemia, acid-base disturbance, edema, contamination and line complications; renal, cardiac and oligoanuric patients, cats and small dogs require particularly tight volume control.

Clinical practicality8.5/10

A ready-to-use sterile isotonic solution fits standard IV sets, pumps and drug-dilution workflows and permits weight-based boluses or infusions. Practicality depends on selecting a bag appropriate to patient size, counting flushes and drug carriers in the total fluid prescription, maintaining asepsis, confirming additive compatibility and discarding compromised or time-expired containers.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Do not select 0.9% saline as routine ongoing fluid in existing hypernatraemia or hyperchloraemia. Measure sodium and corrected chloride, define the desired direction and rate of change, and switch or stop when the compositional target is reached.
  • Fluid overload can be life-threatening and is usually iatrogenic. Use extra caution in heart, kidney or liver disease, oliguria/anuria, pulmonary or peripheral edema, cats and small dogs; count every bolus, infusion, flush, drug carrier, enteral input and ongoing loss, and stop non-beneficial fluid.
  • At 154 mmol/L chloride, large or prolonged volumes can raise chloride and contribute to hyperchloraemic metabolic acidosis and possibly renal vasoconstriction. Recheck electrolytes, blood gas/acid-base status, creatinine, urine output and clinical perfusion; use a buffered balanced crystalloid when it better matches the patient.
  • Do not use 0.9% saline automatically as maintenance or free-water replacement. Its sodium and chloride content exceeds maintenance needs, and sodium disorders require a calculated correction plan with frequent reassessment to avoid dangerous neurologic shifts.
  • Before adding or co-infusing any medicine, confirm compatibility, final concentration, diluent, route, stability and line requirements from that medicine’s own current instructions. Inspect for haze, colour change, particles or precipitate; an isotonic carrier is not proof of chemical compatibility.
  • Prescribe a patient-specific endpoint and reassessment interval rather than a fixed universal rate. During resuscitation give measured aliquots and reassess perfusion after each; during ongoing therapy track body weight, respiratory rate/effort, edema, input/output, blood pressure and laboratory trends.
  • Use an intact, clear, particle-free container, a patient-size-appropriate bag and an accurate pump or volume-limiting device. Maintain catheter and port asepsis, follow the exact product’s post-opening limit, never pool residual fluid between patients, and discard a contaminated, damaged or expired container.
  • Pack size, container material, ports, overwrap, storage and post-opening instructions can differ among these eight exact products. The shared score does not imply interchangeability for pressure infusion, drug compounding, blood-line use or a specific delivery device; verify the exact insert before use.
Assessment sources
  1. NaCl 0.9% infusion market audit2026
  2. B. Braun NaCl 0.9% SmPC2023
  3. FDA NaCl 0.9% label2018
  4. AAHA fluid therapy guideline2024
  5. Canine crystalloid comparison2013
  6. Canine/feline hyperchloremia2025
  7. Small-animal fluid overload2021
Assessed: 22 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Sodium chloride9 mg/ml
Formulation Type
Solution
Administration route
Intravenous
Manufacturer
Liqvor Pharmaceuticals · Armenia
Registration
Georgia Yes, human
In force until 27 Jul 2028
Human (Ministry of Health, RAMA)
In the register: ნატრიუმის ქლორიდი ლიქორი 0.9%, საინფუზიო ხსნარი
№ რ-038724, რ-038725, რ-038726, რ-038727
Verified on: 16 Oct 2026
 EU No
Verified on: 16 Oct 2026
 UK No
Verified on: 16 Oct 2026
 US No
Verified on: 16 Oct 2026
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026

Sodium Chloride Reka-Med 0.9%, Solution

solution for infusion, human medicine
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog Selected IV 0.9% sodium chloride for extracellular-volume replacement, chloride-responsive metabolic alkalosis, or a compatible injectable-drug diluent/flush; not default maintenance, free-water replacement or routine resuscitation fluid
6.6/10
Situational / acceptable
vetman assessment

Sodium Chloride Reka-Med

0.9%, solution for infusion, human medicine
Assessed clinical scopeDog · Selected IV 0.9% sodium chloride for extracellular-volume replacement, chloride-responsive metabolic alkalosis, or a compatible injectable-drug diluent/flush; not default maintenance, free-water replacement or routine resuscitation fluid · Intravenous
Care settingVeterinary clinic or hospital after individual fluid prescription, using a pump or other volume-limiting device and repeated perfusion, body-weight, input/output, electrolyte and acid-base reassessment
vetman score 6.6/10 Situational / acceptable
Evidence confidence: Medium Georgia: Yes, human · № რ-035488, რ-035489, რ-035490 · Verified on 16 Oct 2026 Off-label use

A dependable clinic fluid and diluent when 154 mmol/L sodium and chloride, chloride replacement or specific compatibility is wanted. It should be prescribed like a drug, not continued by habit: balanced crystalloids are usually preferable for routine resuscitation, and volume, chloride, sodium and acid-base effects require reassessment.

Regulatory and scientific credibility5.5/10

The exact 0.9% human infusion has a sourced current Georgian registration and identifiable manufacturer, strength and IV route, while exhaustive current checks record it as not registered in EU/EEA, GB or US. Veterinary administration is off-label and no exact-product veterinary dossier was found.

Clinical efficacy6.5/10

Sodium chloride 0.9% reliably expands extracellular volume and supplies sodium and chloride, and it is useful when its composition or compatibility is specifically wanted. It is not physiologically balanced: current dog/cat guidance generally favours buffered balanced crystalloids for routine resuscitation and warns that high chloride exposure may impair acid-base and renal physiology; veterinary comparative outcome evidence remains limited.

Safety and tolerability6.5/10

Class safety is well characterised, but a public exact-product dossier was not found. Main risks are dose- and rate-related fluid overload, hypernatraemia, hyperchloraemia, acid-base disturbance, edema, contamination and line complications; renal, cardiac and oligoanuric patients, cats and small dogs require particularly tight volume control.

Clinical practicality8.5/10

A ready-to-use sterile isotonic solution fits standard IV sets, pumps and drug-dilution workflows and permits weight-based boluses or infusions. Practicality depends on selecting a bag appropriate to patient size, counting flushes and drug carriers in the total fluid prescription, maintaining asepsis, confirming additive compatibility and discarding compromised or time-expired containers.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Do not select 0.9% saline as routine ongoing fluid in existing hypernatraemia or hyperchloraemia. Measure sodium and corrected chloride, define the desired direction and rate of change, and switch or stop when the compositional target is reached.
  • Fluid overload can be life-threatening and is usually iatrogenic. Use extra caution in heart, kidney or liver disease, oliguria/anuria, pulmonary or peripheral edema, cats and small dogs; count every bolus, infusion, flush, drug carrier, enteral input and ongoing loss, and stop non-beneficial fluid.
  • At 154 mmol/L chloride, large or prolonged volumes can raise chloride and contribute to hyperchloraemic metabolic acidosis and possibly renal vasoconstriction. Recheck electrolytes, blood gas/acid-base status, creatinine, urine output and clinical perfusion; use a buffered balanced crystalloid when it better matches the patient.
  • Do not use 0.9% saline automatically as maintenance or free-water replacement. Its sodium and chloride content exceeds maintenance needs, and sodium disorders require a calculated correction plan with frequent reassessment to avoid dangerous neurologic shifts.
  • Before adding or co-infusing any medicine, confirm compatibility, final concentration, diluent, route, stability and line requirements from that medicine’s own current instructions. Inspect for haze, colour change, particles or precipitate; an isotonic carrier is not proof of chemical compatibility.
  • Prescribe a patient-specific endpoint and reassessment interval rather than a fixed universal rate. During resuscitation give measured aliquots and reassess perfusion after each; during ongoing therapy track body weight, respiratory rate/effort, edema, input/output, blood pressure and laboratory trends.
  • Use an intact, clear, particle-free container, a patient-size-appropriate bag and an accurate pump or volume-limiting device. Maintain catheter and port asepsis, follow the exact product’s post-opening limit, never pool residual fluid between patients, and discard a contaminated, damaged or expired container.
  • Pack size, container material, ports, overwrap, storage and post-opening instructions can differ among these eight exact products. The shared score does not imply interchangeability for pressure infusion, drug compounding, blood-line use or a specific delivery device; verify the exact insert before use.
Assessment sources
  1. NaCl 0.9% infusion market audit2026
  2. B. Braun NaCl 0.9% SmPC2023
  3. FDA NaCl 0.9% label2018
  4. AAHA fluid therapy guideline2024
  5. Canine crystalloid comparison2013
  6. Canine/feline hyperchloremia2025
  7. Small-animal fluid overload2021
Assessed: 22 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Cat Selected IV 0.9% sodium chloride for extracellular-volume replacement, chloride-responsive metabolic alkalosis, or a compatible injectable-drug diluent/flush; not default maintenance, free-water replacement or routine resuscitation fluid
6.6/10
Situational / acceptable
vetman assessment

Sodium Chloride Reka-Med

0.9%, solution for infusion, human medicine
Assessed clinical scopeCat · Selected IV 0.9% sodium chloride for extracellular-volume replacement, chloride-responsive metabolic alkalosis, or a compatible injectable-drug diluent/flush; not default maintenance, free-water replacement or routine resuscitation fluid · Intravenous
Care settingVeterinary clinic or hospital after individual fluid prescription, using a pump or other volume-limiting device and repeated perfusion, body-weight, input/output, electrolyte and acid-base reassessment
vetman score 6.6/10 Situational / acceptable
Evidence confidence: Medium Georgia: Yes, human · № რ-035488, რ-035489, რ-035490 · Verified on 16 Oct 2026 Off-label use

A dependable clinic fluid and diluent when 154 mmol/L sodium and chloride, chloride replacement or specific compatibility is wanted. It should be prescribed like a drug, not continued by habit: balanced crystalloids are usually preferable for routine resuscitation, and volume, chloride, sodium and acid-base effects require reassessment.

Regulatory and scientific credibility5.5/10

The exact 0.9% human infusion has a sourced current Georgian registration and identifiable manufacturer, strength and IV route, while exhaustive current checks record it as not registered in EU/EEA, GB or US. Veterinary administration is off-label and no exact-product veterinary dossier was found.

Clinical efficacy6.5/10

Sodium chloride 0.9% reliably expands extracellular volume and supplies sodium and chloride, and it is useful when its composition or compatibility is specifically wanted. It is not physiologically balanced: current dog/cat guidance generally favours buffered balanced crystalloids for routine resuscitation and warns that high chloride exposure may impair acid-base and renal physiology; veterinary comparative outcome evidence remains limited.

Safety and tolerability6.5/10

Class safety is well characterised, but a public exact-product dossier was not found. Main risks are dose- and rate-related fluid overload, hypernatraemia, hyperchloraemia, acid-base disturbance, edema, contamination and line complications; renal, cardiac and oligoanuric patients, cats and small dogs require particularly tight volume control.

Clinical practicality8.5/10

A ready-to-use sterile isotonic solution fits standard IV sets, pumps and drug-dilution workflows and permits weight-based boluses or infusions. Practicality depends on selecting a bag appropriate to patient size, counting flushes and drug carriers in the total fluid prescription, maintaining asepsis, confirming additive compatibility and discarding compromised or time-expired containers.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Do not select 0.9% saline as routine ongoing fluid in existing hypernatraemia or hyperchloraemia. Measure sodium and corrected chloride, define the desired direction and rate of change, and switch or stop when the compositional target is reached.
  • Fluid overload can be life-threatening and is usually iatrogenic. Use extra caution in heart, kidney or liver disease, oliguria/anuria, pulmonary or peripheral edema, cats and small dogs; count every bolus, infusion, flush, drug carrier, enteral input and ongoing loss, and stop non-beneficial fluid.
  • At 154 mmol/L chloride, large or prolonged volumes can raise chloride and contribute to hyperchloraemic metabolic acidosis and possibly renal vasoconstriction. Recheck electrolytes, blood gas/acid-base status, creatinine, urine output and clinical perfusion; use a buffered balanced crystalloid when it better matches the patient.
  • Do not use 0.9% saline automatically as maintenance or free-water replacement. Its sodium and chloride content exceeds maintenance needs, and sodium disorders require a calculated correction plan with frequent reassessment to avoid dangerous neurologic shifts.
  • Before adding or co-infusing any medicine, confirm compatibility, final concentration, diluent, route, stability and line requirements from that medicine’s own current instructions. Inspect for haze, colour change, particles or precipitate; an isotonic carrier is not proof of chemical compatibility.
  • Prescribe a patient-specific endpoint and reassessment interval rather than a fixed universal rate. During resuscitation give measured aliquots and reassess perfusion after each; during ongoing therapy track body weight, respiratory rate/effort, edema, input/output, blood pressure and laboratory trends.
  • Use an intact, clear, particle-free container, a patient-size-appropriate bag and an accurate pump or volume-limiting device. Maintain catheter and port asepsis, follow the exact product’s post-opening limit, never pool residual fluid between patients, and discard a contaminated, damaged or expired container.
  • Pack size, container material, ports, overwrap, storage and post-opening instructions can differ among these eight exact products. The shared score does not imply interchangeability for pressure infusion, drug compounding, blood-line use or a specific delivery device; verify the exact insert before use.
Assessment sources
  1. NaCl 0.9% infusion market audit2026
  2. B. Braun NaCl 0.9% SmPC2023
  3. FDA NaCl 0.9% label2018
  4. AAHA fluid therapy guideline2024
  5. Canine crystalloid comparison2013
  6. Canine/feline hyperchloremia2025
  7. Small-animal fluid overload2021
Assessed: 22 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Sodium chloride9 mg/ml
Formulation Type
Solution
Administration route
Intravenous
Manufacturer
Reka-Med Pharm
Registration
Georgia Yes, human
In force until 09 Jun 2027
Human (Ministry of Health, RAMA)
In the register: ნატრიუმის ქლორიდი რეკა-მედი 0.9%, საინფუზიო ხსნარი
№ რ-035488, რ-035489, რ-035490
Verified on: 16 Oct 2026
 EU No
Verified on: 16 Oct 2026
 UK No
Verified on: 16 Oct 2026
 US No
Verified on: 16 Oct 2026
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026

Professional reference for veterinary professionals. Not advertising and not a substitute for the product label/SPC.

For veterinary professionals only. It does not replace clinical judgement or the product label; check the dose in the official label (SPC). vetman is not liable for harm caused by using this information.

Trademarks belong to their owners; vetman is not affiliated with the manufacturers and receives no payment from them.

The database is protected under Chapter VII of the Law of Georgia on Copyright and Related Rights; automated or bulk copying is prohibited.

This reference is still growing. Missing a product? Let us know. · Report an error or request an addition · Updated: 23 Oct 2026

All of this shows in vetman as you prescribe

The dose for the patient's weight, registration in Georgia and controlled status, right on the prescription.

Register Demo ↗